WO2008081017A1 - New n-alkynylcarboxamide derivatives - Google Patents

New n-alkynylcarboxamide derivatives Download PDF

Info

Publication number
WO2008081017A1
WO2008081017A1 PCT/EP2008/050014 EP2008050014W WO2008081017A1 WO 2008081017 A1 WO2008081017 A1 WO 2008081017A1 EP 2008050014 W EP2008050014 W EP 2008050014W WO 2008081017 A1 WO2008081017 A1 WO 2008081017A1
Authority
WO
WIPO (PCT)
Prior art keywords
alkyl
halogen atoms
het
group
diseases
Prior art date
Application number
PCT/EP2008/050014
Other languages
French (fr)
Inventor
Pierre-Yves Coqueron
Marie-Claire Grosjean-Cournoyer
Jörg GREUL
Darren James Mansfield
Benoît HARTMANN
Amos Mattes
Klaus Kunz
Rüdiger Fischer
Original Assignee
Bayer Cropscience Ag
Gaertzen, Oliver
Ort, Oswald
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Cropscience Ag, Gaertzen, Oliver, Ort, Oswald filed Critical Bayer Cropscience Ag
Publication of WO2008081017A1 publication Critical patent/WO2008081017A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D339/00Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/08Six-membered rings

Definitions

  • the present invention relates to novel N-alkynylcarboxamide derivatives, their process of preparation, their use as fungicides, particularly in the form of fungicidal compositions, and methods for the control of phytopathogenic fungi of plants using these compounds or their compositions.
  • the present invention relates to a N-alkynylcarboxamide derivative of general formula (I)
  • - R 1 is a hydrogen atom, a halogen atom, a Ci-C ⁇ -alkyl, a C 2 -C 6 -alkenyl, a C 2 -C6-alkynyl, a tri(Ci-C8-alkyl)silyl, a Cs-C ⁇ -cycloalkyl or a C3-C6- halogenocycloalkyl having 1 to 5 halogen atoms;
  • - R 2 and R 3 are chosen independently of each other as being a hydrogen atom, a halogen atom, a d-C ⁇ -alkyl, a C 2 -C6-alkenyl, a C 2 -C6-alkynyl, a In(C 1 -C 8 - alkyl)silyl, a Cs-C ⁇ -cycloalkyl or a Cs-C ⁇ -halogenocycloalkyl having 1 to 5 halogen atoms;
  • R 4 and R 5 are chosen independently of each other as being a hydrogen atom, a halogen atom, a d-C ⁇ -alkyl, a d-C ⁇ -alkenyl, a d-C ⁇ -alkynyl, a In(C 1 -C 8 - alkyl)silyl, a Cs-C ⁇ -cycloalkyl or a Cs-C ⁇ -halogenocycloalkyl having 1 to 5 halogen atoms; or R 2 or R 3 may form together with R 4 or R 5 a C 3 -C 7 -cycloalkyl; - R 6 is a hydrogen atom, a d-C ⁇ -alkyl, or a Cs-Cycycloalkyl; and
  • Het represents a 5-, 6- or 7-membered non-fused heterocycle with one, two or three heteroatoms which may be the same or different, Het being linked by a carbon atom; Het being substituted in ortho position by a substituent chosen as being a halogen atom, a nitro group, a cyano group, a sulfanyl group, a pentafluoro- ⁇ 6 - sulfanyl group, a Ci-Cs-alkyl, a Ci-Cs-halogenoalkyl having 1 to 5 halogen atoms, a C 2 -C 8 -alkenyl, a C 2 -C 8 -alkynyl, a Ci-Cs-alkoxy, a Ci-Cs-halogenoalkoxy having 1 to 5 halogen atoms, a Ci-C8-alkoxy-C 2 -C8-alkenyl, a Ci-Cs-alkylsulf
  • - halogen means fluorine, bromine, chlorine or iodine
  • an alkyl group, an alkenyl group, and an alkynyl group as well as moieties containing these terms, can be linear or branched;
  • - heteroatom means sulphur, nitrogen or oxygen.
  • any of the compounds of the present invention can exist in one or more optical or chiral isomer forms depending on the number of asymmetric centres in the compound.
  • the invention thus relates equally to all the optical isomers and to their racemic or scalemic mixtures (the term "scalemic” denotes a mixture of enantiomers in different proportions), and to the mixtures of all the possible stereoisomers, in all proportions.
  • the diastereoisomers and/or the optical isomers can be separated according to the methods which are known per se by the man ordinary skilled in the art.
  • Any of the compounds of the present invention can also exist in one or more geometric isomer forms depending on the number of double bonds in the compound.
  • the invention thus relates equally to all geometric isomers and to all possible mixtures, in all proportions.
  • the geometric isomers can be separated according to general methods, which are known per se by the man ordinary skilled in the art. Any of the compounds of general formula (I) wherein X represents a hydroxy, a sulfanyl group or an amino group may be found in its tautomeric form resulting from the shift of the proton of said hydroxy, sulfanyl or amino group. Such tautomeric forms of such compounds are also part of the present invention.
  • the carbon atom of the alkynyl moiety of compound of formula (I) is substituted by R 1 ; R 1 being as defined above.
  • R 1 is chosen as being a hydrogen atom, a Ci-C ⁇ -alkyl or a C 3 -C 7 -cycloalkyl.
  • the carbon atoms of the ethylamide moiety of compound of formula (I) are substituted by R 2 , R 3 , R 4 and R 5 ; R 2 , R 3 , R 4 and R 5 being as defined above.
  • the present invention also relates to N- alkynylcarboxamide derivative of general formula (I) in which in which the different characteristics may be chosen alone or in combination as being :
  • R 2 and R 3 are chosen independently of each other as being a hydrogen atom, a Ci-C ⁇ -alkyl or a C 3 -Cy-cycloalkyl;
  • R 4 and R 5 are chosen independently of each other as being a hydrogen atom, a Ci-C ⁇ -alkyl or a C 3 -Cy-cycloalkyl;
  • R 2 or R 3 form together with R 4 or R 5 a C 3 -C 7 -cycloalkyl. More preferably, C 3 -C 7 - cycloalkyl is chosen as being cyclohexyl.
  • the nitrogen atom of the amide moiety of the compound of formula (I) is substituted by R 7 , R 7 being a hydrogen atom, a C 1 -C 6 - alkyl or a C 3 -C 7 -cycloalkyl.
  • the C 3 -Cy-cycloalkyl is cyclopropyl.
  • Het of the compound of general formula (I) is a 5-, 6- or 7-membered non-fused heterocycle with one, two or three heteroatoms which may be the same or different, Het being linked by a carbon atom and being substituted in ortho position and optionally substituted in any other position by substituents as defined above.
  • the present invention also relates to N-alkynylcarboxamide derivative of general formula (I) in which the different characteristics may be chosen alone or in combination as being :
  • - Het is chosen as being 2-furan, 3-furan, 4,5-dihydro-3-furan, 2-thiophene, 3- thiophene, 2-pyrrole, 3-pyrrole, 5-oxazole, 4-oxazole, 5-thiazole, 4-thiazole, 5- pyrazole, 4-pyrazole, 3-pyrazole, 3-isoxazole, 4-isoxazole, 5-isoxazole, 3-isothiazole, 4-1,2,3-triazole, 4-thiadiazole, 5-thidiazole, 2-pyridine, 3-pyridine, 4-pyridine, 2- oxathiine, 4,5dihydro-3-pyran, 4,5dihydro-2-thiopyran, 4,5dihydro-3-thiopyran or 2- pyrazine;
  • - Het is substituted in ortho position by a halogen atom, a Ci-Cs-alkyl, a Ci-Cs- halogenoalkyl having 1 to 5 halogen atoms, a Ci-Cs-alkoxy or a C 1 -C 8 - halogenoalkoxy having 1 to 5 halogen atoms; and
  • - Het is substituted in any other position than ortho-position by a halogen atom or a Ci-Cs-alkyL.
  • Het of the compound of general formula (I) may be a five membered ring heterocycle.
  • Specific examples of compounds of the present invention where Het is a five membered heterocycle include : * Het represents a heterocycle of the general formula (Het-1)
  • R 7 and R 8 may be the same or different and may be a hydrogen atom, a halogen atom, an amino group, a nitro group, a d-G t -alkyl or a Ci-C 4 -halogenoalkyl having 1 to 5 halogen atoms; and - R 9 may be a halogen atom, a nitro group, a Ci-C4-alkyl or a C1-C4- halogenoalkyl having 1 to 5 halogen atoms.
  • Het represents a heterocycle of the general formula (Het-2)
  • - R 10 may be a hydrogen atom, a halogen atom , a Ci-C 4 -alkyl or a C 1 -C 4 - halogenoalkyl having 1 to 5 halogen atoms;
  • R 11 and R 12 may be the same or different and may be a hydrogen atom, a halogen atom, an amino group, a Ci-C4-alkyl or a Ci-C4-halogenoalkyl having 1 to 5 halogen atoms; provided that the R 10 and R 12 are not both a hydrogen atom.
  • Het represents a heterocycle of the general formula (Het-3)
  • - R 13 may be a halogen atom, a Ci-C 4 -alkyl or a Ci-C 4 -halogenoalkyl having 1 to 5 halogen atoms; and - R 14 may be a hydrogen atom, a Ci-C 4 -alkyl or a Ci-C 4 -halogenoalkyl having
  • Het represents a heterocycle of the general formula (Het-4)
  • Het-4 in which : - R 15 and R 16 may be the same or different and may be a hydrogen atom, a halogen atom, a Ci-C 4 -alkyl, a Ci-C 4 -halogenoalkyl having 1 to 5 halogen atoms, a Ci-C 4 -alkylthio, a Ci-C 4 -alkylsulphonyl, a phenyl optionally substituted by a halogen atom or a Ci-C 4 -alkyl or a pyridyl otpionally substituted by a halogen atom or a Ci- C 4 -alkyl; and
  • R 17 may be a halogen atom, a cyano group, a Ci-C 4 -alkyl, a C 1 -C 4 - halogenoalkyl having 1 to 5 halogen atoms or a Ci-C 4 -halogenoalkoxy having 1 to 5 halogen atoms.
  • Het represents a heterocycle of the general formula (Het-5)
  • R 18 and R 19 may be the same or different and may be a hydrogen atom, a halogen atom, a Ci-C 4 -alkyl, a Ci-C 4 -alkyloxy or a Ci-C 4 -halogenoalkyl having 1 to
  • R 20 may be a hydrogen atom, a halogen atom, a Ci-C 4 -alkyl or a C 1 -C 4 - halogenoalkyl having 1 to 5 halogen atoms; provided that the R 19 and R 20 are not both a hydrogen atom.
  • Het represents a heterocycle of the general formula (Het-6)
  • - R 21 may be a hydrogen atom, a halogen atom, a cyano group, a Ci-C 4 -alkyl or a Ci-C 4 -halogenoalkyl having 1 to 5 halogen atoms;
  • - R 22 and R 24 may be the same or different and may be a hydrogen atom, a halogen atom, a Ci-C 4 -alkyl or a Ci-C 4 -halogenoalkyl having 1 to 5 halogen atoms; and
  • R 23 may be a hydrogen atom, a cyano group, a Ci-C 4 -alkyl, a C 1 -C 4 - halogenoalkyl having 1 to 5 halogen atoms, a Ci-C 4 -alkoxy-Ci-C 4 -alkyl, a hydroxy- Ci-C 4 -alkyl, a Ci-C 4 -alkylsulphonyl, a di(Ci-C 4 -alkyl)aminosulphonyl, a Ci-C 6 - alkylcarbonyl, a phenylsulphonyl optionally substituted by a halogen atom or a Ci- C 4 -alkyl, or a benzoyl optionally substituted by a halogen atom or a Ci-C 4 -alkyl; provided that the R 21 and R 24 are not both a hydrogen atom.
  • Het represents a heterocycle of the general formula (Het-7)
  • R 25 may be a hydrogen atom, a cyano group, a Ci-C 4 -alkyl, a C 1 -C 4 - halogenoalkyl having 1 to 5 halogen atoms, a Ci-C 4 -alkoxy-Ci-C 4 -alkyl, a hydroxy- Ci-C 4 -alkyl, a Ci-C 4 -alkylsulphonyl, a di(Ci-C 4 -alkyl)aminosulphonyl, a C 1 -C 6 - alkylcarbonyl, a phenylsulphonyl optionally substituted by a halogen atom or a Ci- C 4 -alkyl, or a benzoyl optionally substituted by a halogen atom or a Ci-C 4 -alkyl; and
  • R 26 , R 27 and R 28 may be the same or different and may be a hydrogen atom, a halogen atom, a cyano group, a Ci-C 4 -alkyl, a Ci-C 4 -halogenoalkyl having 1 to 5 halogen atoms or a Ci-C 4 -alkylcarbonyl; provided that R 25 and R 28 are not both a hydrogen atom.
  • Het represents a heterocycle of the general formula (Het-8)
  • R 29 may be a hydrogen atom or a d-G t -alkyl
  • R 30 may be a halogen atom, a d-G t -alkyl or a Ci-C 4 -halogenoalkyl having 1 to 5 halogen atoms.
  • Het represents a heterocycle of the general formula (Het-9)
  • R 31 may be a hydrogen atom or a Ci-C 4 -alkyl
  • R 32 may be a halogen atom, a Ci-C 4 -alkyl, a Ci-C 4 -halogenoalkyl having 1 to 5 halogen atoms or a phenyl optionally substituted by a halogen atom or a C 1 -C 4 - alkyl.
  • Het represents a heterocycle of the general formula (Het-10)
  • R 33 may be a hydrogen atom, a halogen atom, an amino group, a cyano group, a Ci-C4-alkylamino, a di-(Ci-C4-alkyl)amino, a Ci-C4-alkyl, a C1-C4- halogenoalkyl having 1 to 5 halogen atoms or a phenyl optionally substituted by a halogen atom or a Ci-C 4 -alkyl; and
  • R 34 may be a halogen atom, a Ci-C 4 -alkyl or a Ci-C 4 -halogenoalkyl having 1 to 5 halogen atoms.
  • Het represents a heterocycle of the general formula (Het-11)
  • - R 35 may be a hydrogen atom, a halogen atom, an amino group, a cyano group, a Ci-C 4 -alkylamino, a di-(Ci-C 4 -alkyl)amino, a Ci-C 4 -alkyl or a C 1 -C 4 - halogenoalkyl having 1 to 5 halogen atoms; and -R 36 may be a halogen atom, a Ci-C 4 -alkyl or a Ci-C 4 -halogenoalkyl having 1 to 5 halogen atoms.
  • Het represents a heterocycle of the general formula (Het-12)
  • R 37 may be a halogen atom, a cyano group, a nitro group, a Ci-C 4 -alkyl, a Ci-C4-halogenoalkyl having 1 to 5 halogen atoms, a Cs-C ⁇ -cycloalkyl, a C 1 -C 4 - alkoxy, a Ci-C4-halogenoalkoxy having 1 to 5 halogen atoms, a Ci-C4-alkylthio, a Ci-C4-halogenoalkylthio having 1 to 5 halogen atoms, an amino carbonyl group or an aminocarbonyl-Ci-C 4 -alkyl;
  • - R 38 may be a hydrogen atom, a halogen atom, a cyano group, a nitro group, a Ci-C4-alkyl, a Ci-C4-alkoxy or a Ci-C4-alkylthio; and - R 39 may be a hydrogen atom, a phenyl, a Ci-C 4 -alkyl, a C 1 -C 4 - halogenoalkyl having 1 to 5 halogen atoms, a hydroxy-Ci-C 4 -alkyl, a C 2 -C 6 -alkenyl, a C 3 -C 6 -cycloalkyl, a Ci-C 4 -alkylthio-Ci-C 4 -alkyl, a Ci-C 4 -halogenoalkylthio-Ci-C 4 - alkyl having 1 to 5 halogen atoms, a Ci-C 4 -alkoxy-Ci-C
  • Het represents a heterocycle of the general formula (Het- 13)
  • R 40 may be a hydrogen atom, a halogen atom, a cyano group, a nitro group, a Ci-C 4 -alkyl, a Ci-C 4 -halogenoalkyl having 1 to 5 halogen atoms, a C 3 -C 6 - cycloalkyl, a Ci-C4-alkoxy, a Ci-C4-halogenoalkoxy having 1 to 5 halogen atoms, a Ci-C4-alkylthio, a Ci-C4-halogenoalkylthio having 1 to 5 halogen atoms, an aminocarbonyl or an aminocarbonyl-Ci-C 4 -alkyl;
  • R 41 may be a hydrogen atom, a halogen atom, a cyano group, a Ci-C 4 -alkyl, a Ci-C4-alkoxy, a Ci-C4-halogenoalkoxy having 1 to 5 halogen atoms or a C 1 -C 4 - alkylthio; and - R 42 may be a hydrogen atom, a Ci-C 4 -alkyl, a Ci-C 4 -halogenoalkyl having 1 to 5 halogen atoms, a a C 2 -C 6 -alkenyl, a Cs-C ⁇ -cycloalkyl, a Ci-C 4 -alkylthio-Ci-C 4 -alkyl, a Ci-C 4 -halogenoalkylthio-Ci-C 4 -alkyl having 1 to 5 halogen atoms, a Ci-C 4 -alkoxy-Ci-C 4 -alkyl
  • Het represents a heterocycle of the general formula (Het-14)
  • -R 43 may be a hydrogen atom, a halogen atom, a cyano group, a nitro group, a Ci-C 4 -alkyl, a Ci-C 4 -halogenoalkyl having 1 to 5 halogen atoms, a Cs-C ⁇ -cycloalkyl, a Ci-C 4 -alkoxy, a Ci-C 4 -halogenoalkoxy having 1 to 5 halogen atoms, a Ci-C 4 - alkylthio, a Ci-C 4 -halogenoalkylthio having 1 to 5 halogen atoms, an aminocarbonyl, or an aminocarbonyl-Ci-C 4 -alkyl;
  • R 44 may be a hydrogen atom, a halogen atom, a cyano group, a Ci-C 4 -alkyl, a Ci-C 4 -alkoxy, a Ci-C 4 -alkylthio or a Ci-C 4 -halogenoalky having 1 to 5 halogen atoms;
  • R 45 may be a hydrogen atom, a phenyl, a benzyl, a Ci-C 4 -alkyl, a C 1 -C 4 - halogenoalkyl having 1 to 5 halogen atoms, a hydroxy-Ci-C 4 -alkyl, a C 2 -C 6 -alkenyl, a C 3 -C 6 -cycloalkyl, a Ci-C 4 -alkylthio-Ci-C 4 -alkyl, a Ci-C 4 -halogenoalkylthio-Ci-C 4 - alkyl having 1 to 5 halogen atoms, a Ci-C 4 -alkoxy-Ci-C 4 -alkyl, a Ci-C 4 - halogenoalkoxy-Ci-C 4 -alkyl having 1 to 5 halogen atoms; provided that R 44 and R 45 are not both a hydrogen atom.
  • Het represents a heterocycle of the general formula (Het- 15)
  • R - R , 47 may be a halogen atom, a C-C 4 -alkyl or a Ci-C 4 -halogenoalkyl having 1 to 5 halogen atoms.
  • Het represents a heterocycle of the general formula (Het-16)
  • R 48 and R 49 may be the same or different and may be a hydrogen atom, a halogen atom, a Ci-C 4 -alkyl, a Ci-C 4 -halogenoalkyl having 1 to 5 halogen atoms, a phenyl optionally substituted by a halogen atom or a Ci-C 4 -alkyl, or a heterocyclyl optionally substituted by a halogen atom or a Ci-C 4 -alkyl; provided that R 48 and R 49 are not both a hydrogen atom.
  • Het represents a heterocycle of the general formula (Het- 17)
  • R 50 may be a halogen atom, a Ci-C 4 -alkyl or a Ci-C 4 -halogenoalkyl having 1 to 5 halogen atoms, and
  • - R , 51 may be a halogen atom, a Ci-C 4 -alkyl or a Ci-C 4 -halogenoalkyl having 1 to 5 halogen atoms.
  • Het represents a heterocycle of the general formula (Het- 18)
  • R 52 may be a halogen atom, a Ci-C 4 -alkyl or a Ci-C 4 -halogenoalkyl having 1 to 5 halogen atoms.
  • Het represents a heterocycle of the general formula (Het-19)
  • - R 53 may be a halogen atom, a Ci-C 4 -alkyl or a Ci-C 4 -halogenoalkyl having 1 to 5 halogen atoms; and - R 54 may be a hydrogen atom, a Ci-C 4 -alkyl, a Ci-C 4 -halogenoalkyl having 1 to 5 halogen atoms, or a phenyl optionally substituted by a halogen atom or a C 1 -C 4 - alkyl.
  • Het represents a heterocycle of the general formula (Het-20)
  • R 55 may be a halogen atom, a Ci-C 4 -alkyl or a Ci-C 4 -halogenoalkyl having 1 to 5 halogen atoms.
  • Het of the compound of general formula (I) may be a six membered ring heterocycle.
  • Specific examples of compounds of the present invention where Het is a six membered heterocycle include :
  • Het represents a heterocycle of the general formula (Het-21)
  • - R 56 may be a halogen atom, a hydroxy group, a cyano group, a Ci-C 4 -alkyl, a Ci-C 4 -halogenoalkyl having 1 to 5 halogen atoms, a Ci-C 4 -alkoxy, a C 1 -C 4 - alkylthio, a Ci-C4-halogenoalkylthio having 1 to 5 halogen atoms or a C1-C4- halogenoalkoxy having 1 to 5 halogen atoms; and - R 57 , R 58 and R 59 , which may be the same or different, may be a hydrogen atom, a halogen atom, a cyano group, a Ci-C 4 -alkyl, a Ci-C 4 -halogenoalkyl having 1 to 5 halogen atoms, a Ci-C4-alkoxy, a Ci-C4-alkylthio,
  • Het represents a heterocycle of the general formula (Het-22)
  • - R > 60 may be a hydrogen atom, a halogen atom, a hydroxy group, a cyano group, a Ci-C 4 -alkyl, a Ci-C 4 -halogenoalkyl having 1 to 5 halogen atoms, a C 1 -C 4 - alkoxy, a Ci-Cs-alkylthio, a C2-Cs-alkenylthio a Ci-C4-halogenoalkylthio having 1 to 5 halogen atoms, a Ci-C4-halogenoalkoxy having 1 to 5 halogen atoms, a phenyloxy optionally substituted by a halogen atom or a Ci-C 4 -alkyl, or a phenylthio optionally substituted by a halogen atom or a Ci-C 4 -alkyl;
  • R 61 , R 62 and R 63 which may the same or different, may be a hydrogen atom, a halogen atom, a cyano group, a Ci-C 4 -alkyl, a Ci-C 4 -halogenoalkyl having 1 to 5 halogen atoms, a Ci-C4-alkoxy, a Ci-C4-alkylthio, a Ci-C4-halogenoalkoxy having 1 to 5 halogen atoms, a Ci-C 4 -alkylsulphinyl, a Ci-C 4 -alkylsulphonyl or a N- morpholine optionally substituted by a halogen atom or a Ci-C 4 -alkyl, or a thienyl optionally substituted by a halogen atom or a Ci-C 4 -alkyl; provided that the R 60 and R 63 are not both a hydrogen atom.
  • Het represents a heterocycle of the general formula (Het-23)
  • R 64 , R 65 , R 66 and R 67 which may be the same or different, may be a hydrogen atom, a halogen atom, a hydroxy group, a cyano group, a C 1 -C 4 - alkyl, a Ci-C 4 -halogenoalkyl having 1 to 5 halogen atoms, a Ci-C 4 -alkoxy, a C 1 -C 4 - alkylthio, a Ci-C4-halogenoalkylthio having 1 to 5 halogen atoms, a C1-C4- halogenoalkoxy having 1 to 5 halogen atoms, a Ci-C 4 -alkylsulphinyl or a C 1 -C 4 - alkylsulphonyl; provided that the R 64 and R 67 are not both a hydrogen atom.
  • Het represents a hetero cycle of the general formula (Het-24)
  • R 68 may be a halogen atom, a Ci-C 4 -alkyl or a Ci-C 4 -halogenoalkyl having 1 to 5 halogen atoms;
  • R 69 may be a hydrogen atom, a Ci-C 4 -alkyl, a Ci-C 4 -halogenoalkyl having 1 to 5 halogen atoms, a Ci-C ⁇ -alkoxycarbonyl, a benzyl optionally substituted by 1 to 3 halogen atoms, a benzyloxycarbonyl optionally substituted by 1 to 3 halogen atoms or a heterocyclyl.
  • Het represents a heterocycle of the general formula (Het-25)
  • R 70 may be a halogen atom, a hydroxy group, a cyano group, a Ci-C 4 -alkyl, a Ci-C 4 -halogenoalkyl having 1 to 5 halogen atoms, a Ci-C 4 -alkoxy, a C 1 -C 4 - alkylthio, a Ci-C4-halogenoalkylthio having 1 to 5 halogen atoms or a C1-C4- halogenoalkoxy having 1 to 5 halogen atoms;
  • R 71 may be a hydrogen atom, a Ci-C 4 -alkyl, a Ci-C 4 -halogenoalkyl having 1 to 5 halogen atoms or a benzyl.
  • Het represents a heterocycle of the general formula (Het-26)
  • - Q 1 may be a sulphur atom, -SO-, -SO 2 - or -CH 2 -;
  • R 72 may be a Ci-C 4 -alkyl or a Ci-C 4 -halogenoalkyl having 1 to 5 halogen atoms;
  • R 73 and R 74 may be the same or different and may be a hydrogen atom or a Ci-C 4 -alkyl.
  • Het represents a heterocycle of the general formula (Het-27)
  • R 75 may be a Ci-C 4 -alkyl or a Ci-C 4 -halogenoalkyl having 1 to 5 halogen atoms.
  • Het represents a heterocycle of the general formula (Het-28)
  • R 76 may be a Ci-C 4 -alkyl or a Ci-C 4 -halogenoalkyl having 1 to 5 halogen atoms.
  • Het represents a heterocycle of the general formula (Het-29)
  • R 77 may be a halogen atom, a Ci-C 4 -alkyl or a Ci-C 4 -halogenoalkyl having 1 to 5 halogen atoms.
  • the present invention also relates to a process for the preparation of the compound of general formula (I).
  • a process for the preparation of compound of general formula (I) as defined above which comprises reacting a N-alkynylcarboxamide derivative of general formula (II) or one of its salt :
  • R 1 , R 2 , R 3 , R 4 , R 5 , and R 6 are as defined above;
  • - Het is as defined above; and - L 1 is a leaving group chosen as being a halogen atom, a hydroxyl group, -OR a , - OCOR a , R a being a Ci-C 6 alkyl, a Ci-C 6 haloalkyl, a benzyl, 4-methoxybenzyl, pentafluorophenyl or a group of formula ⁇ O T , ⁇ Het
  • the process according to the present invention is conducted in the presence of a catalyst.
  • Suitable catalyst may be chosen as being 4-dimethyl-aminopyridine, 1- hydroxy-benzotriazole or dimethylformamide.
  • L 1 is a hydroxy group
  • the process according to the present invention is conducted in the presence of condensing agent.
  • Suitable condensing agent may be chosen as being acid halide former, such as phosgene, phosphorous tribromide, phosphorous trichloride, phosphorous pentachloride, phosphorous trichloride oxide or thionyl chloride; anhydride former, such as ethyl chloroformate, methyl chloroformate, isopropyl chloroformate, isobutyl chloroformate or methanesulfonyl- chloride; carbodiimides, such as N,N'-dicyclohexylcarbodiimide (DCC) or other customary condensing agents, such as phosphorous pentoxide, polyphosphoric acid, N,N'-carbonyl-diimidazole, 2-ethoxy-N-ethoxycarbonyl- 1 ,2-dihydroquino line
  • acid halide former such as phosgene, phosphorous tribromide, phosphorous trichloride,
  • EEDQ triphenylphosphine/tetrachloromethane
  • the compound according to the present invention can be prepared according to the general processes of preparation described above. It will nevertheless be understood that, on the basis of his general knowledge and of available publications, the skilled worker will be able to adapt this method according to the specifics of each of the compounds, which it is desired to synthesise.
  • the present invention also relates to a fungicidal composition
  • a fungicidal composition comprising an effective amount of an active material of general formula (I).
  • a fungicidal composition comprising, as an active ingredient, an effective amount of a compound of general formula (I) as defined above and an agriculturally acceptable support, carrier or filler.
  • the term "support” denotes a natural or synthetic, organic or inorganic material with which the active material is combined to make it easier to apply, notably to the parts of the plant.
  • This support is thus generally inert and should be agriculturally acceptable.
  • the support may be a solid or a liquid.
  • suitable supports include clays, natural or synthetic silicates, silica, resins, waxes, solid fertilisers, water, alcohols, in particular butanol, organic solvents, mineral and plant oils and derivatives thereof. Mixtures of such supports may also be used.
  • composition may also comprise additional components.
  • the composition may further comprise a surfactant.
  • the surfactant can be an emulsifier, a dispersing agent or a wetting agent of ionic or non-ionic type or a mixture of such surfactants.
  • the presence of at least one surfactant is generally essential when the active material and/or the inert support are water-insoluble and when the vector agent for the application is water.
  • surfactant content may be comprised between 5% and 40% by weight of the composition.
  • additional components may also be included, e.g. protective colloids, adhesives, thickeners, thixotropic agents, penetration agents, stabilisers, sequestering agents.
  • the active materials can be combined with any solid or liquid additive, which complies with the usual formulation techniques.
  • compositions according to the invention may contain from 0.05 to 99% (by weight) of active material, preferably 10 to 70% by weight.
  • Compositions according to the present invention can be used in various forms such as aerosol dispenser, capsule suspension, cold fogging concentrate, dustable powder, emulsif ⁇ able concentrate, emulsion oil in water, emulsion water in oil, encapsulated granule, fine granule, flowable concentrate for seed treatment, gas (under pressure),gas generating product, granule, hot fogging concentrate, macrogranule, microgranule, oil dispersible powder, oil miscible flowable concentrate, oil miscible liquid, paste, plant rodlet, powder for dry seed treatment, seed coated with a pesticide, soluble concentrate, soluble powder, solution for seed treatment, suspension concentrate (flowable concentrate), ultra low volume (ulv) liquid, ultra low volume (ulv) suspension, water dispersible granules or tablets, water dispersible powder for slurry treatment, water soluble granules or tablets, water
  • compositions include not only compositions which are ready to be applied to the plant or seed to be treated by means of a suitable device, such as a spraying or dusting device, but also concentrated commercial compositions which must be diluted before application to the crop.
  • the compounds of the invention can also be mixed with one or more insecticides, fungicides, bactericides, attractant acaricides or pheromones or other compounds with biological activity.
  • the mixtures thus obtained have a broadened spectrum of activity.
  • the mixtures with other fungicides are particularly advantageous.
  • fungicide mixing partners may be selected in the following lists :
  • a compound capable to inhibit the nucleic acid synthesis like benalaxyl, benalaxyl-M, bupirimate, chiralaxyl, clozylacon, dimethirimol, ethirimol, furalaxyl, hymexazol, mefenoxam, metalaxyl, metalaxyl-M, ofurace, oxadixyl, oxolinic acid ;
  • a compound capable to inhibit the mitosis and cell division like benomyl, carbendazim, diethofencarb, ethaboxam, fuberidazole, pencycuron, thiabendazole thiophanate-methyl, zoxamide;
  • a compound capable to inhibit the respiration for example as Cl-respiration inhibitor like diflumetorim; as Cll-respiration inhibitor like boscalid, carboxin, fenfuram, flutolanil, furametpyr, furmecyclox, mepronil, oxycarboxine, penthiopyrad, thifluzamide; as CHI-respiration inhibitor like amisulbrom, azoxystrobin, cyazofamid, dimoxystrobin, enestrobin, famoxadone, fenamidone, fluoxastrobin, kresoxim- methyl, metominostrobin, orysastrobin, picoxystrobin, pyraclostrobin, trifloxystrobin;
  • Cl-respiration inhibitor like diflumetorim
  • Cll-respiration inhibitor like boscalid, carboxin, fenfuram, flutolanil, furametpyr, furmecyclox, mepronil
  • a compound capable to inhibit ATP production like fentin acetate, fentin chloride, fentin hydroxide, silthiofam;
  • a compound capable to inhibit lipid and membrane synthesis like biphenyl, chlozolinate, edifenphos, etridiazole, iodocarb, iprobenfos, iprodione, isoprothiolane, procymidone, propamocarb, propamocarb hydrochloride, pyrazophos, tolclofos- methyl, vinclozolin ; 9) a compound capable to inhibit ergosterol biosynthesis like aldimorph, azaconazole, bitertanol, bromuconazole, cyproconazole, diclobutrazole, difenoconazole, diniconazole, diniconazole-M, dodemorph, dodemorph acetate, epoxiconazole, etaconazole, fenarimol, fenbuconazole, fenhexamid, fenpropidin, fen
  • a compound capable to have a multisite action like Bordeaux mixture, captafol, captan, chlorothalonil, copper naphthenate, copper oxide, copper oxychloride, copper preparations such as copper hydroxide, copper sulphate, dichlofluanid, dithianon, dodine, dodine free base, ferbam, fluorofolpet, folpet, guazatine, guazatine acetate, iminoctadine, iminoctadine albesilate, iminoctadine triacetate, mancopper, mancozeb, maneb, metiram, metiram zinc, oxine-copper, propineb, sulphur and sulphur preparations including calcium polysulphide, thiram, tolylfluanid, zineb, ziram;
  • composition according to the invention comprising a mixture of a compound of formula (I) with a bactericide compound may also be particularly advantageous.
  • suitable bactericide mixing partners may be selected in the following list : bronopol, dichlorophen, nitrapyrin, nickel dimethyldithiocarbamate, kasugamycin, octhilinone, furancarboxylic acid, oxytetracycline, probenazole, streptomycin, tecloftalam, copper sulphate and other copper preparations.
  • the fungicidal compositions of the present invention can be used to curatively or preventively control the phytopathogenic fungi of crops.
  • a method for curatively or preventively controlling the phytopathogenic fungi of crops characterised in that a fungicidal composition as hereinbefore defined is applied to the seed, the plant and/or to the fruit of the plant or to the soil in which the plant is growing or in which it is desired to grow.
  • composition as used against phytopathogenic fungi of crops comprises an effective and non-phytotoxic amount of an active material of general formula (I).
  • an effective and non-phytotoxic amount means an amount of composition according to the invention which is sufficient to control or destroy the fungi present or liable to appear on the crops, and which does not entail any appreciable symptom of phytotoxicity for the said crops. Such an amount can vary within a wide range depending on the fungus to be controlled, the type of crop, the climatic conditions and the compounds included in the fungicidal composition according to the invention.
  • the method of treatment according to the present invention is useful to treat propagation material such as tubers or rhizomes, but also seeds, seedlings or seedlings pricking out and plants or plants pricking out. This method of treatment can also be useful to treat roots.
  • the method of treatment according to the present invention can also be useful to treat the overground parts of the plant such as trunks, stems or stalks, leaves, flowers and fruits of the concerned plant.
  • cotton Among the plants that can be protected by the method according to the present invention, mention may be made of cotton; flax; vine; fruit or vegetable crops such as Rosaceae sp. (for instance pip fruit such as apples and pears, but also stone fruit such as apricots, almonds and peaches), Ribesioidae sp., Juglandaceae sp., Betulaceae sp., Anacardiaceae sp., Fagaceae sp., Moraceae sp., Oleaceae sp., Actinidaceae sp., Lauraceae sp., Musaceae sp.
  • Rosaceae sp. for instance pip fruit such as apples and pears, but also stone fruit such as apricots, almonds and peaches
  • Rosaceae sp. for instance pip fruit such as apples and pears, but also stone fruit such as apricots, almonds and peaches
  • Rubiaceae sp. for instance banana trees and plantins
  • Rubiaceae sp. Theaceae sp., Sterculiceae sp., Rutaceae sp. (for instance lemons, oranges and grapefruit); Solanaceae sp. (for instance tomatoes), Liliaceae sp., Asteraceae sp. (for instance lettuces), Umbelliferae sp., Cruciferae sp., Chenopodiaceae sp., Cucurbitaceae sp., Papilionaceae sp. (for instance peas), Rosaceae sp. (for instance strawberries); major crops such as Graminae sp.
  • Asteraceae sp. for instance sunflower
  • Cruciferae sp. for instance colza
  • Fabacae sp. for instance peanuts
  • Papilionaceae sp. for instance soybean
  • Solanaceae sp. for instance potatoes
  • Chenopodiaceae sp. for instance beetroots
  • horticultural and forest crops as well as genetically modified homologues of these crops.
  • Powdery mildew diseases such as :
  • Blumeria diseases caused for example by Blumeria graminis
  • Podosphaera diseases caused for example by Podosphaera leucotricha
  • Sphaerotheca diseases caused for example by Sphaerotheca fuliginea
  • Uncinula diseases caused for example by Uncinula necator
  • Rust diseases such as :
  • Gymnosporangium diseases caused for example by Gymnosporangium sabinae
  • Hemileia diseases caused for example by Hemileia vastatrix
  • Phakopsora diseases caused for example by Phakopsora pachyrhizi or Phakopsora meibomiae
  • Puccinia diseases caused for example by Puccinia recondita
  • Uromyces diseases caused for example by Uromyces appendiculatus
  • Oomycete diseases such as :
  • Bremia diseases caused for example by Bremia lactucae
  • Peronospora diseases caused for example by Peronospora pisi or P. brassicae
  • Phytophthora diseases caused for example by Phytophthora infestans
  • Plasmopara diseases caused for example by Plasmopara viticola
  • Pseudoperonospora diseases caused for example by Pseudoperonospora humuli or Pseudoperonospora cubensis
  • Plasmopara diseases caused for example by Plasmopara viticola
  • Pseudoperonospora diseases caused for example by Pseudoperonospora humuli or Pseudoperonospora cubensis
  • Pythium diseases caused for example by Pythium ultimum;
  • Leafspot, leaf blotch and leaf blight diseases such as :
  • Alternaria diseases caused for example by Alternaria solani
  • Cercospora diseases caused for example by Cercospora beticola
  • Cladiosporum diseases caused for example by Cladiosporium cucumerinum
  • Cochlio bolus diseases caused for example by Cochliobolus sativus
  • Colletotrichum diseases caused for example by Colletotrichum lindemuthanium
  • Cycloconium diseases caused for example by Cycloconium oleaginum
  • Diaporthe diseases caused for example by Diaporthe citri
  • Elsinoe diseases caused for example by Elsinoe fawcettii
  • Gloeosporium diseases caused for example by Gloeosporium laeticolor
  • Glomerella diseases caused for example by Glomerella cingulata
  • Guignardia diseases caused for example by Guignardia bidwelli;
  • Leptosphaeria diseases caused for example by Leptosphaeria maculans; Leptosphaeria nodorum;
  • Magnaporthe diseases caused for example by Magnaporthe grisea
  • Mycosphaerella diseases caused for example by Mycosphaerella graminicola; Mycosphaerella arachidicola; Mycosphaerella fijiensis;
  • Phaeosphaeria diseases caused for example by Phaeosphaeria nodorum
  • Pyrenophora diseases caused for example by Pyrenophora teres
  • Ramularia diseases caused for example by Ramularia collo-cygni;
  • Rhynchosporium diseases caused for example by Rhynchosporium secalis
  • Septoria diseases caused for example by Septoria apii or Septoria lycopercisi;
  • Typhula diseases caused for example by Typhula incarnata
  • Venturia diseases caused for example by Venturia inaequalis
  • Root and stem diseases such as :
  • Corticium diseases caused for example by Corticium graminearum
  • Fusarium diseases caused for example by Fusarium oxysporum
  • Gaeumannomyces diseases caused for example by Gaeumannomyces graminis;
  • Rhizoctonia diseases caused for example by Rhizoctonia solani;
  • Tapesia diseases caused for example by Tapesia acuformis
  • Thielaviopsis diseases caused for example by Thielaviopsis basicola
  • Ear and panicle diseases such as : Alternaria diseases, caused for example by Alternaria spp.;
  • Aspergillus diseases caused for example by Aspergillus flavus;
  • Cladosporium diseases caused for example by Cladosporium spp.;
  • Claviceps diseases caused for example by Claviceps purpurea
  • Fusarium diseases caused for example by Fusarium culmorum
  • Gibberella diseases caused for example by Gibber ella zeae
  • Monographella diseases caused for example by Monographella nivalis; Smut and bunt diseases such as :
  • Sphacelotheca diseases caused for example by Sphacelotheca reiliana
  • Tilletia diseases caused for example by Tilletia caries
  • Urocystis diseases caused for example by Urocystis occulta
  • Ustilago diseases caused for example by Ustilago nuda; Fruit rot and mould diseases such as :
  • Aspergillus diseases caused for example by Aspergillus flavus;
  • Botrytis diseases caused for example by Botrytis cinerea
  • Penicillium diseases caused for example by Penicillium expansum
  • Sclerotinia diseases caused for example by Sclerotinia sclerotiorum
  • Verticilium diseases caused for example by Verticilium alboatrum; Seed and soilborne decay, mould, wilt, rot and damping-off diseases :
  • Fusarium diseases caused for example by Fusarium culmorum
  • Phytophthora diseases caused for example by Phytophthora cactorum
  • Pythium diseases caused for example by Pythium ultimum
  • Rhizoctonia diseases caused for example by Rhizoctonia solani;
  • Sclerotium diseases caused for example by Sclerotium rolfsii;
  • Microdochium diseases caused for example by Microdochium nivale; Canker, broom and dieback diseases such as : Nectria diseases, caused for example by Nectria galligena;
  • Blight diseases such as :
  • Monilinia diseases caused for example by Monilinia laxa;
  • Leaf blister or leaf curl diseases such as :
  • Taphrina diseases caused for example by Taphrina deformans; Decline diseases of wooden plants such as :
  • Esca diseases caused for example by Phaemoniella clamydospora; Diseases of flowers and Seeds such as :
  • Botrytis diseases caused for example by Botrytis cinerea
  • Diseases of tubers such as : Rhizoctonia diseases, caused for example by Rhizoctonia solani;
  • Helminthosporium diseases caused for example by Helminthosporium solani.
  • the fungicide composition according to the present invention may also be used against fungal diseases liable to grow on or inside timber.
  • the term "timber" means all types of species of wood, and all types of working of this wood intended for construction, for example solid wood, high-density wood, laminated wood, and plywood.
  • the method for treating timber according to the invention mainly consists in contacting one or more compounds of the present invention, or a composition according to the invention; this includes for example direct application, spraying, dipping, injection or any other suitable means.
  • the dose of active material usually applied in the treatment according to the present invention is generally and advantageously between 10 and 800 g/ha, preferably between 50 and 300 g/ha for applications in foliar treatment.
  • the dose of active substance applied is generally and advantageously between 2 and 200 g per 100 kg of seed, preferably between 3 and 15O g per 100 kg of seed in the case of seed treatment. It is clearly understood that the doses indicated above are given as illustrative examples of the invention. A person skilled in the art will know how to adapt the application doses according to the nature of the crop to be treated.
  • the fungicidal composition according to the present invention may also be used in the treatment of genetically modified organisms with the compounds according to the invention or the agrochemical compositions according to the invention.
  • Genetically modified plants are plants into whose genome a heterologous gene encoding a protein of interest has been stably integrated.
  • the expression "heterologous gene encoding a protein of interest” essentially means genes which give the transformed plant new agronomic properties, or genes for improving the agronomic quality of the transformed plant.
  • compositions according to the present invention may also be used for the preparation of composition useful to curatively or preventively treat human and animal fungal diseases such as, for example, mycoses, dermatoses, trichophyton diseases and candidiases or diseases caused by Aspergillus spp., for example Aspergillus fumigatus.
  • fungal diseases such as, for example, mycoses, dermatoses, trichophyton diseases and candidiases or diseases caused by Aspergillus spp., for example Aspergillus fumigatus.
  • M+l means the molecular ion peak, plus or minus 1 a.m.u. (atomic mass units) respectively, as observed in mass spectroscopy and M (Apcl+) means the molecular ion peak as it was found via positive atmospheric pressure chemical ionisation in mass spectroscopy.
  • Example A in vivo test on Mycosphaerella graminicola (Wheat Leaf Spot)
  • the active ingredients tested are prepared by homogenization in a mixture of DMSO/acetone/tween, then diluted with water to obtain the desired active material concentration.
  • Wheat plants (Scipion variety), sown on a 50/50 peat soil-pozzolana substrate in starter cups and grown at 12°C, are treated at the 1-leaf stage (10 cm tall) by spraying with the aqueous suspension described above. Plants, used as controls, are treated with an aqueous solution not containing the active material.
  • the plants are contaminated by spraying them with an aqueous suspension of Mycosphaerella graminicola spores (500 000 spores per ml).
  • the spores are collected from a 7-day-old culture .
  • the contaminated wheat plants are incubated for 72 hours at 18°C and at 100% relative humidity, and then for 21 to 28 days at 90% relative humidity.

Abstract

A compound of general formula (I). A process for preparing this compound. A fungicidal composition comprising a compound of general formula (I). A method for treating plants by applying a compound of general formula (I) or a composition comprising it.

Description

New N-alkynylcarboxamide derivatives
The present invention relates to novel N-alkynylcarboxamide derivatives, their process of preparation, their use as fungicides, particularly in the form of fungicidal compositions, and methods for the control of phytopathogenic fungi of plants using these compounds or their compositions.
International Patent Application WO 92/05159 describes 2-phenyl-pyrimidine derivatives and their use as fungicides. However, compounds according to the present invention are not disclosed in that patent application.
It is always of high-interest in the field of agrochemicals to use novel pesticidal compounds with a high efficacy to limit and reduce the risk of appearance of resistant strains in the fungi to be treated. We have now found a new family of compounds which shows a fungicidal activity.
Accordingly, the present invention relates to a N-alkynylcarboxamide derivative of general formula (I)
Figure imgf000002_0001
in which :
- R1 is a hydrogen atom, a halogen atom, a Ci-Cβ-alkyl, a C2-C6-alkenyl, a C2-C6-alkynyl, a tri(Ci-C8-alkyl)silyl, a Cs-Cβ-cycloalkyl or a C3-C6- halogenocycloalkyl having 1 to 5 halogen atoms; - R2 and R3 are chosen independently of each other as being a hydrogen atom, a halogen atom, a d-Cβ-alkyl, a C2-C6-alkenyl, a C2-C6-alkynyl, a In(C1-C8- alkyl)silyl, a Cs-Cβ-cycloalkyl or a Cs-Cβ-halogenocycloalkyl having 1 to 5 halogen atoms;
- R4 and R5 are chosen independently of each other as being a hydrogen atom, a halogen atom, a d-Cβ-alkyl, a d-Cβ-alkenyl, a d-Cβ-alkynyl, a In(C1-C8- alkyl)silyl, a Cs-Cβ-cycloalkyl or a Cs-Cβ-halogenocycloalkyl having 1 to 5 halogen atoms; or R2 or R3 may form together with R4 or R5 a C3-C7-cycloalkyl; - R6 is a hydrogen atom, a d-Cβ-alkyl, or a Cs-Cycycloalkyl; and
- Het represents a 5-, 6- or 7-membered non-fused heterocycle with one, two or three heteroatoms which may be the same or different, Het being linked by a carbon atom; Het being substituted in ortho position by a substituent chosen as being a halogen atom, a nitro group, a cyano group, a sulfanyl group, a pentafluoro-λ6- sulfanyl group, a Ci-Cs-alkyl, a Ci-Cs-halogenoalkyl having 1 to 5 halogen atoms, a C2-C8-alkenyl, a C2-C8-alkynyl, a Ci-Cs-alkoxy, a Ci-Cs-halogenoalkoxy having 1 to 5 halogen atoms, a Ci-C8-alkoxy-C2-C8-alkenyl, a Ci-Cs-alkylsulfanyl or a Ci-Cs- halogenoalkylsulfanyl having 1 to 5 halogen atoms; and optionally substituted in any other position by one or further substituents chosen independently of each other from a halogen atom, a nitro group, a cyano group, a sulfanyl group, a pentafluoro-λ6- sulfanyl group, a formyl group, a formyloxy group, a formylamino group, a carboxy group, a Ci-Cs-alkyl, a Ci-Cs-halogenoalkyl having 1 to 5 halogen atoms, a C2-Cs- alkenyl, a C2-Cs-alkynyl, a Ci-Cs-alkoxy, a Ci-Cs-halogenoalkoxy having 1 to 5 halogen atoms, a Ci-Cs-alkoxy-C2-Cs-alkenyl, a Ci-Cs-alkylsulfanyl or a Ci-Cs- halogenoalkylsulfanyl having 1 to 5 halogen atoms; as well as its salts, N-oxydes, metallic complexes, metalloidic complexes and optically active isomers.
In the context of the present invention :
- halogen means fluorine, bromine, chlorine or iodine, -carboxy means -C(=O)OH ;
- carbonyl means -C(=O)- ;
- carbamoyl means -Q=O)NH2 ; - N-hydroxycarbamoyl means -C(=O)NHOH ;
- an alkyl group, an alkenyl group, and an alkynyl group as well as moieties containing these terms, can be linear or branched; and
- heteroatom means sulphur, nitrogen or oxygen.
In the context of the present invention, it has also to be understood that in the case of di-substituted amino and of di-substituted carbamoyl radicals, the two substituents may form together with the nitrogen atom bearing them a saturated heterocyclic ring containing 3 to 7 atoms.
Any of the compounds of the present invention can exist in one or more optical or chiral isomer forms depending on the number of asymmetric centres in the compound. The invention thus relates equally to all the optical isomers and to their racemic or scalemic mixtures (the term "scalemic" denotes a mixture of enantiomers in different proportions), and to the mixtures of all the possible stereoisomers, in all proportions. The diastereoisomers and/or the optical isomers can be separated according to the methods which are known per se by the man ordinary skilled in the art. Any of the compounds of the present invention can also exist in one or more geometric isomer forms depending on the number of double bonds in the compound. The invention thus relates equally to all geometric isomers and to all possible mixtures, in all proportions. The geometric isomers can be separated according to general methods, which are known per se by the man ordinary skilled in the art. Any of the compounds of general formula (I) wherein X represents a hydroxy, a sulfanyl group or an amino group may be found in its tautomeric form resulting from the shift of the proton of said hydroxy, sulfanyl or amino group. Such tautomeric forms of such compounds are also part of the present invention. More generally speaking, all tautomeric forms of compounds of general formula (I) wherein X represents a hydroxy, a sulfanyl group or an amino group, as well as the tautomeric forms of the compounds which can optionally be used as intermediates in the preparation processes, and which will be defined in the description of these processes, are also part of the present invention.
According to the present invention, the carbon atom of the alkynyl moiety of compound of formula (I) is substituted by R1; R1 being as defined above. Preferably, R1 is chosen as being a hydrogen atom, a Ci-Cβ-alkyl or a C3-C7-cycloalkyl.
According to the present invention, the carbon atoms of the ethylamide moiety of compound of formula (I) are substituted by R2, R3, R4 and R5 ; R2, R3, R4 and R5 being as defined above. Preferably, the present invention also relates to N- alkynylcarboxamide derivative of general formula (I) in which in which the different characteristics may be chosen alone or in combination as being :
- as regards R2 and R3, R2 and R3 are chosen independently of each other as being a hydrogen atom, a Ci-Cβ-alkyl or a C3-Cy-cycloalkyl;
- as regards R4 and R5, R4 and R5 are chosen independently of each other as being a hydrogen atom, a Ci-Cβ-alkyl or a C3-Cy-cycloalkyl;
- R2 or R3 form together with R4 or R5 a C3-C7-cycloalkyl. More preferably, C3-C7- cycloalkyl is chosen as being cyclohexyl. According to the present invention, the nitrogen atom of the amide moiety of the compound of formula (I) is substituted by R7, R7 being a hydrogen atom, a C1-C6- alkyl or a C3-C7-cycloalkyl. Preferably, the C3-Cy-cycloalkyl is cyclopropyl.
According to the present invention, "Het" of the compound of general formula (I) is a 5-, 6- or 7-membered non-fused heterocycle with one, two or three heteroatoms which may be the same or different, Het being linked by a carbon atom and being substituted in ortho position and optionally substituted in any other position by substituents as defined above. Preferably, the present invention also relates to N-alkynylcarboxamide derivative of general formula (I) in which the different characteristics may be chosen alone or in combination as being :
- Het is chosen as being 2-furan, 3-furan, 4,5-dihydro-3-furan, 2-thiophene, 3- thiophene, 2-pyrrole, 3-pyrrole, 5-oxazole, 4-oxazole, 5-thiazole, 4-thiazole, 5- pyrazole, 4-pyrazole, 3-pyrazole, 3-isoxazole, 4-isoxazole, 5-isoxazole, 3-isothiazole, 4-1,2,3-triazole, 4-thiadiazole, 5-thidiazole, 2-pyridine, 3-pyridine, 4-pyridine, 2- oxathiine, 4,5dihydro-3-pyran, 4,5dihydro-2-thiopyran, 4,5dihydro-3-thiopyran or 2- pyrazine;
- Het is substituted in ortho position by a halogen atom, a Ci-Cs-alkyl, a Ci-Cs- halogenoalkyl having 1 to 5 halogen atoms, a Ci-Cs-alkoxy or a C1-C8- halogenoalkoxy having 1 to 5 halogen atoms; and
- Het is substituted in any other position than ortho-position by a halogen atom or a Ci-Cs-alkyL.
According to the present invention, "Het" of the compound of general formula (I) may be a five membered ring heterocycle. Specific examples of compounds of the present invention where Het is a five membered heterocycle include : * Het represents a heterocycle of the general formula (Het-1)
Figure imgf000005_0001
in which :
- R7 and R8 may be the same or different and may be a hydrogen atom, a halogen atom, an amino group, a nitro group, a d-Gt-alkyl or a Ci-C4-halogenoalkyl having 1 to 5 halogen atoms; and - R9 may be a halogen atom, a nitro group, a Ci-C4-alkyl or a C1-C4- halogenoalkyl having 1 to 5 halogen atoms.
* Het represents a heterocycle of the general formula (Het-2)
Figure imgf000006_0001
in which : - R10 may be a hydrogen atom, a halogen atom , a Ci-C4-alkyl or a C1-C4- halogenoalkyl having 1 to 5 halogen atoms; and
- R11 and R12 may be the same or different and may be a hydrogen atom, a halogen atom, an amino group, a Ci-C4-alkyl or a Ci-C4-halogenoalkyl having 1 to 5 halogen atoms; provided that the R10 and R12 are not both a hydrogen atom.
* Het represents a heterocycle of the general formula (Het-3)
Figure imgf000006_0002
(Het-3) in which :
- R13 may be a halogen atom, a Ci-C4-alkyl or a Ci-C4-halogenoalkyl having 1 to 5 halogen atoms; and - R14 may be a hydrogen atom, a Ci-C4-alkyl or a Ci-C4-halogenoalkyl having
1 to 5 halogen atoms.
* Het represents a heterocycle of the general formula (Het-4)
Figure imgf000006_0003
(Het-4) in which : - R15 and R16 may be the same or different and may be a hydrogen atom, a halogen atom, a Ci-C4-alkyl, a Ci-C4-halogenoalkyl having 1 to 5 halogen atoms, a Ci-C4-alkylthio, a Ci-C4-alkylsulphonyl, a phenyl optionally substituted by a halogen atom or a Ci-C4-alkyl or a pyridyl otpionally substituted by a halogen atom or a Ci- C4-alkyl; and
- R17 may be a halogen atom, a cyano group, a Ci-C4-alkyl, a C1-C4- halogenoalkyl having 1 to 5 halogen atoms or a Ci-C4-halogenoalkoxy having 1 to 5 halogen atoms.
* Het represents a heterocycle of the general formula (Het-5)
Figure imgf000007_0001
(Het-5) in which :
- R18 and R19 may be the same or different and may be a hydrogen atom, a halogen atom, a Ci-C4-alkyl, a Ci-C4-alkyloxy or a Ci-C4-halogenoalkyl having 1 to
5 halogen atoms; and
- R20 may be a hydrogen atom, a halogen atom, a Ci-C4-alkyl or a C1-C4- halogenoalkyl having 1 to 5 halogen atoms; provided that the R19 and R20 are not both a hydrogen atom.
* Het represents a heterocycle of the general formula (Het-6)
Figure imgf000007_0002
in which :
- R21 may be a hydrogen atom, a halogen atom, a cyano group, a Ci-C4-alkyl or a Ci-C4-halogenoalkyl having 1 to 5 halogen atoms; - R22 and R24 may be the same or different and may be a hydrogen atom, a halogen atom, a Ci-C4-alkyl or a Ci-C4-halogenoalkyl having 1 to 5 halogen atoms; and
- R23 may be a hydrogen atom, a cyano group, a Ci-C4-alkyl, a C1-C4- halogenoalkyl having 1 to 5 halogen atoms, a Ci-C4-alkoxy-Ci-C4-alkyl, a hydroxy- Ci-C4-alkyl, a Ci-C4-alkylsulphonyl, a di(Ci-C4-alkyl)aminosulphonyl, a Ci-C6- alkylcarbonyl, a phenylsulphonyl optionally substituted by a halogen atom or a Ci- C4-alkyl, or a benzoyl optionally substituted by a halogen atom or a Ci-C4-alkyl; provided that the R21 and R24 are not both a hydrogen atom.
* Het represents a heterocycle of the general formula (Het-7)
Figure imgf000008_0001
in which :
- R25 may be a hydrogen atom, a cyano group, a Ci-C4-alkyl, a C1-C4- halogenoalkyl having 1 to 5 halogen atoms, a Ci-C4-alkoxy-Ci-C4-alkyl, a hydroxy- Ci-C4-alkyl, a Ci-C4-alkylsulphonyl, a di(Ci-C4-alkyl)aminosulphonyl, a C1-C6- alkylcarbonyl, a phenylsulphonyl optionally substituted by a halogen atom or a Ci- C4-alkyl, or a benzoyl optionally substituted by a halogen atom or a Ci-C4-alkyl; and
- R26, R27 and R28 may be the same or different and may be a hydrogen atom, a halogen atom, a cyano group, a Ci-C4-alkyl, a Ci-C4-halogenoalkyl having 1 to 5 halogen atoms or a Ci-C4-alkylcarbonyl; provided that R25 and R28 are not both a hydrogen atom.
* Het represents a heterocycle of the general formula (Het-8)
Figure imgf000008_0002
(Het-8) in which :
- R29 may be a hydrogen atom or a d-Gt-alkyl; and
- R30 may be a halogen atom, a d-Gt-alkyl or a Ci-C4-halogenoalkyl having 1 to 5 halogen atoms.
* Het represents a heterocycle of the general formula (Het-9)
Figure imgf000008_0003
in which :
- R31 may be a hydrogen atom or a Ci-C4-alkyl; and
- R32 may be a halogen atom, a Ci-C4-alkyl, a Ci-C4-halogenoalkyl having 1 to 5 halogen atoms or a phenyl optionally substituted by a halogen atom or a C1-C4- alkyl.
* Het represents a heterocycle of the general formula (Het-10)
Figure imgf000009_0001
(Het-10) in which :
- R33 may be a hydrogen atom, a halogen atom, an amino group, a cyano group, a Ci-C4-alkylamino, a di-(Ci-C4-alkyl)amino, a Ci-C4-alkyl, a C1-C4- halogenoalkyl having 1 to 5 halogen atoms or a phenyl optionally substituted by a halogen atom or a Ci-C4-alkyl; and
- R34 may be a halogen atom, a Ci-C4-alkyl or a Ci-C4-halogenoalkyl having 1 to 5 halogen atoms.
* Het represents a heterocycle of the general formula (Het-11)
Figure imgf000009_0002
(Het-11) in which :
- R35 may be a hydrogen atom, a halogen atom, an amino group, a cyano group, a Ci-C4-alkylamino, a di-(Ci-C4-alkyl)amino, a Ci-C4-alkyl or a C1-C4- halogenoalkyl having 1 to 5 halogen atoms; and -R36 may be a halogen atom, a Ci-C4-alkyl or a Ci-C4-halogenoalkyl having 1 to 5 halogen atoms. * Het represents a heterocycle of the general formula (Het-12)
Figure imgf000010_0001
in which :
- R37 may be a halogen atom, a cyano group, a nitro group, a Ci-C4-alkyl, a Ci-C4-halogenoalkyl having 1 to 5 halogen atoms, a Cs-Cβ-cycloalkyl, a C1-C4- alkoxy, a Ci-C4-halogenoalkoxy having 1 to 5 halogen atoms, a Ci-C4-alkylthio, a Ci-C4-halogenoalkylthio having 1 to 5 halogen atoms, an amino carbonyl group or an aminocarbonyl-Ci-C4-alkyl;
- R38 may be a hydrogen atom, a halogen atom, a cyano group, a nitro group, a Ci-C4-alkyl, a Ci-C4-alkoxy or a Ci-C4-alkylthio; and - R39 may be a hydrogen atom, a phenyl, a Ci-C4-alkyl, a C1-C4- halogenoalkyl having 1 to 5 halogen atoms, a hydroxy-Ci-C4-alkyl, a C2-C6-alkenyl, a C3-C6-cycloalkyl, a Ci-C4-alkylthio-Ci-C4-alkyl, a Ci-C4-halogenoalkylthio-Ci-C4- alkyl having 1 to 5 halogen atoms, a Ci-C4-alkoxy-Ci-C4-alkyl or a C1-C4- halogenoalkoxy-Ci-C4-alkyl having 1 to 5 halogen atoms.
* Het represents a heterocycle of the general formula (Het- 13)
Figure imgf000010_0002
in which :
- R40 may be a hydrogen atom, a halogen atom, a cyano group, a nitro group, a Ci-C4-alkyl, a Ci-C4-halogenoalkyl having 1 to 5 halogen atoms, a C3-C6- cycloalkyl, a Ci-C4-alkoxy, a Ci-C4-halogenoalkoxy having 1 to 5 halogen atoms, a Ci-C4-alkylthio, a Ci-C4-halogenoalkylthio having 1 to 5 halogen atoms, an aminocarbonyl or an aminocarbonyl-Ci-C4-alkyl;
- R41 may be a hydrogen atom, a halogen atom, a cyano group, a Ci-C4-alkyl, a Ci-C4-alkoxy, a Ci-C4-halogenoalkoxy having 1 to 5 halogen atoms or a C1-C4- alkylthio; and - R42 may be a hydrogen atom, a Ci-C4-alkyl, a Ci-C4-halogenoalkyl having 1 to 5 halogen atoms, a
Figure imgf000011_0001
a C2-C6-alkenyl, a Cs-Cβ-cycloalkyl, a Ci-C4-alkylthio-Ci-C4-alkyl, a Ci-C4-halogenoalkylthio-Ci-C4-alkyl having 1 to 5 halogen atoms, a Ci-C4-alkoxy-Ci-C4-alkyl, a Ci-C4-halogenoalkoxy-Ci-C4-alkyl having 1 to 5 halogen atoms or a phenyl optionally substituted by a halogen atom, a Ci-C4-alkyl, a Ci-C4-alkoxyalkyl or a nitro group; provided that the R40 and R41 are not both a hydrogen atom.
* Het represents a heterocycle of the general formula (Het-14)
Figure imgf000011_0002
in which :
-R43 may be a hydrogen atom, a halogen atom, a cyano group, a nitro group, a Ci-C4-alkyl, a Ci-C4-halogenoalkyl having 1 to 5 halogen atoms, a Cs-Cβ-cycloalkyl, a Ci-C4-alkoxy, a Ci-C4-halogenoalkoxy having 1 to 5 halogen atoms, a Ci-C4- alkylthio, a Ci-C4-halogenoalkylthio having 1 to 5 halogen atoms, an aminocarbonyl, or an aminocarbonyl-Ci-C4-alkyl;
- R44 may be a hydrogen atom, a halogen atom, a cyano group, a Ci-C4-alkyl, a Ci-C4-alkoxy, a Ci-C4-alkylthio or a Ci-C4-halogenoalky having 1 to 5 halogen atoms;
- R45 may be a hydrogen atom, a phenyl, a benzyl, a Ci-C4-alkyl, a C1-C4- halogenoalkyl having 1 to 5 halogen atoms, a hydroxy-Ci-C4-alkyl, a C2-C6-alkenyl, a C3-C6-cycloalkyl, a Ci-C4-alkylthio-Ci-C4-alkyl, a Ci-C4-halogenoalkylthio-Ci-C4- alkyl having 1 to 5 halogen atoms, a Ci-C4-alkoxy-Ci-C4-alkyl, a Ci-C4- halogenoalkoxy-Ci-C4-alkyl having 1 to 5 halogen atoms; provided that R44 and R45 are not both a hydrogen atom.
* Het represents a heterocycle of the general formula (Het- 15)
Figure imgf000011_0003
(Het- 15) in which :
- R46 m naayy bbee aa hydrogen atom, a halogen atom, a C-C4-alkyl or a C1-C4- halogenoalkyl having 1 to 5 halogen atoms; and
- R , 47 may be a halogen atom, a C-C4-alkyl or a Ci-C4-halogenoalkyl having 1 to 5 halogen atoms.
* Het represents a heterocycle of the general formula (Het-16)
Figure imgf000012_0001
in which R48 and R49 may be the same or different and may be a hydrogen atom, a halogen atom, a Ci-C4-alkyl, a Ci-C4-halogenoalkyl having 1 to 5 halogen atoms, a phenyl optionally substituted by a halogen atom or a Ci-C4-alkyl, or a heterocyclyl optionally substituted by a halogen atom or a Ci-C4-alkyl; provided that R48 and R49 are not both a hydrogen atom.
* Het represents a heterocycle of the general formula (Het- 17)
Figure imgf000012_0002
in which
- R50 may be a halogen atom, a Ci-C4-alkyl or a Ci-C4-halogenoalkyl having 1 to 5 halogen atoms, and
- R , 51 may be a halogen atom, a Ci-C4-alkyl or a Ci-C4-halogenoalkyl having 1 to 5 halogen atoms.
* Het represents a heterocycle of the general formula (Het- 18)
Figure imgf000012_0003
in which R52 may be a halogen atom, a Ci-C4-alkyl or a Ci-C4-halogenoalkyl having 1 to 5 halogen atoms. * Het represents a heterocycle of the general formula (Het-19)
Figure imgf000013_0001
(Het-19)
in which :
- R53 may be a halogen atom, a Ci-C4-alkyl or a Ci-C4-halogenoalkyl having 1 to 5 halogen atoms; and - R54 may be a hydrogen atom, a Ci-C4-alkyl, a Ci-C4-halogenoalkyl having 1 to 5 halogen atoms, or a phenyl optionally substituted by a halogen atom or a C1-C4- alkyl.
* Het represents a heterocycle of the general formula (Het-20)
Figure imgf000013_0002
(Het-20) in which R55 may be a halogen atom, a Ci-C4-alkyl or a Ci-C4-halogenoalkyl having 1 to 5 halogen atoms.
According to the present invention, "Het" of the compound of general formula (I) may be a six membered ring heterocycle. Specific examples of compounds of the present invention where Het is a six membered heterocycle include :
* Het represents a heterocycle of the general formula (Het-21)
Figure imgf000013_0003
(Het-21) in which :
- R56 may be a halogen atom, a hydroxy group, a cyano group, a Ci-C4-alkyl, a Ci-C4-halogenoalkyl having 1 to 5 halogen atoms, a Ci-C4-alkoxy, a C1-C4- alkylthio, a Ci-C4-halogenoalkylthio having 1 to 5 halogen atoms or a C1-C4- halogenoalkoxy having 1 to 5 halogen atoms; and - R57, R58 and R59, which may be the same or different, may be a hydrogen atom, a halogen atom, a cyano group, a Ci-C4-alkyl, a Ci-C4-halogenoalkyl having 1 to 5 halogen atoms, a Ci-C4-alkoxy, a Ci-C4-alkylthio, a Ci-C4-halogenoalkoxy having 1 to 5 halogen atoms, a Ci-C4-alkylsulphinyl or a Ci-C4-alkylsulphonyl.
* Het represents a heterocycle of the general formula (Het-22)
Figure imgf000014_0001
(Het-22) in which :
- R > 60 may be a hydrogen atom, a halogen atom, a hydroxy group, a cyano group, a Ci-C4-alkyl, a Ci-C4-halogenoalkyl having 1 to 5 halogen atoms, a C1-C4- alkoxy, a Ci-Cs-alkylthio, a C2-Cs-alkenylthio a Ci-C4-halogenoalkylthio having 1 to 5 halogen atoms, a Ci-C4-halogenoalkoxy having 1 to 5 halogen atoms, a phenyloxy optionally substituted by a halogen atom or a Ci-C4-alkyl, or a phenylthio optionally substituted by a halogen atom or a Ci-C4-alkyl;
- R61, R62 and R63, which may the same or different, may be a hydrogen atom, a halogen atom, a cyano group, a Ci-C4-alkyl, a Ci-C4-halogenoalkyl having 1 to 5 halogen atoms, a Ci-C4-alkoxy, a Ci-C4-alkylthio, a Ci-C4-halogenoalkoxy having 1 to 5 halogen atoms, a Ci-C4-alkylsulphinyl, a Ci-C4-alkylsulphonyl or a N- morpholine optionally substituted by a halogen atom or a Ci-C4-alkyl, or a thienyl optionally substituted by a halogen atom or a Ci-C4-alkyl; provided that the R60 and R63 are not both a hydrogen atom.
* Het represents a heterocycle of the general formula (Het-23)
Figure imgf000014_0002
(Het-23) in which R64, R65, R66 and R67, which may be the same or different, may be a hydrogen atom, a halogen atom, a hydroxy group, a cyano group, a C1-C4- alkyl, a Ci-C4-halogenoalkyl having 1 to 5 halogen atoms, a Ci-C4-alkoxy, a C1-C4- alkylthio, a Ci-C4-halogenoalkylthio having 1 to 5 halogen atoms, a C1-C4- halogenoalkoxy having 1 to 5 halogen atoms, a Ci-C4-alkylsulphinyl or a C1-C4- alkylsulphonyl; provided that the R64 and R67 are not both a hydrogen atom.
* Het represents a hetero cycle of the general formula (Het-24)
Figure imgf000015_0001
(Het-24) in which :
- R68 may be a halogen atom, a Ci-C4-alkyl or a Ci-C4-halogenoalkyl having 1 to 5 halogen atoms;
- R69 may be a hydrogen atom, a Ci-C4-alkyl, a Ci-C4-halogenoalkyl having 1 to 5 halogen atoms, a Ci-Cβ-alkoxycarbonyl, a benzyl optionally substituted by 1 to 3 halogen atoms, a benzyloxycarbonyl optionally substituted by 1 to 3 halogen atoms or a heterocyclyl.
* Het represents a heterocycle of the general formula (Het-25)
Figure imgf000015_0002
in which :
- R70 may be a halogen atom, a hydroxy group, a cyano group, a Ci-C4-alkyl, a Ci-C4-halogenoalkyl having 1 to 5 halogen atoms, a Ci-C4-alkoxy, a C1-C4- alkylthio, a Ci-C4-halogenoalkylthio having 1 to 5 halogen atoms or a C1-C4- halogenoalkoxy having 1 to 5 halogen atoms;
- R71 may be a hydrogen atom, a Ci-C4-alkyl, a Ci-C4-halogenoalkyl having 1 to 5 halogen atoms or a benzyl.
* Het represents a heterocycle of the general formula (Het-26)
Figure imgf000015_0003
in which : - Q1 may be a sulphur atom, -SO-, -SO2- or -CH2-;
- R72 may be a Ci-C4-alkyl or a Ci-C4-halogenoalkyl having 1 to 5 halogen atoms; and
- R73 and R74 may be the same or different and may be a hydrogen atom or a Ci-C4-alkyl.
* Het represents a heterocycle of the general formula (Het-27)
Figure imgf000016_0001
in which R75 may be a Ci-C4-alkyl or a Ci-C4-halogenoalkyl having 1 to 5 halogen atoms.
* Het represents a heterocycle of the general formula (Het-28)
Figure imgf000016_0002
(Het-28) in which R76 may be a Ci-C4-alkyl or a Ci-C4-halogenoalkyl having 1 to 5 halogen atoms.
* Het represents a heterocycle of the general formula (Het-29)
Figure imgf000016_0003
(Het-29) in which R77 may be a halogen atom, a Ci-C4-alkyl or a Ci-C4-halogenoalkyl having 1 to 5 halogen atoms.
The present invention also relates to a process for the preparation of the compound of general formula (I). Thus, according to a further aspect of the present invention there is provided a process for the preparation of compound of general formula (I) as defined above, which comprises reacting a N-alkynylcarboxamide derivative of general formula (II) or one of its salt :
Figure imgf000017_0001
(H)
in which R1, R2, R3, R4, R5, and R6 are as defined above;
Figure imgf000017_0002
in which :
- Het is as defined above; and - L1 is a leaving group chosen as being a halogen atom, a hydroxyl group, -ORa, - OCORa, Ra being a Ci-C6 alkyl, a Ci-C6 haloalkyl, a benzyl, 4-methoxybenzyl, pentafluorophenyl or a group of formula ^O T, ^Het
O in the presence of a catalyst and, if L is a hydroxyl group, in the presence of a condensing agent.
The process according to the present invention is conducted in the presence of a catalyst. Suitable catalyst may be chosen as being 4-dimethyl-aminopyridine, 1- hydroxy-benzotriazole or dimethylformamide. In case L1 is a hydroxy group, the process according to the present invention is conducted in the presence of condensing agent. Suitable condensing agent may be chosen as being acid halide former, such as phosgene, phosphorous tribromide, phosphorous trichloride, phosphorous pentachloride, phosphorous trichloride oxide or thionyl chloride; anhydride former, such as ethyl chloroformate, methyl chloroformate, isopropyl chloroformate, isobutyl chloroformate or methanesulfonyl- chloride; carbodiimides, such as N,N'-dicyclohexylcarbodiimide (DCC) or other customary condensing agents, such as phosphorous pentoxide, polyphosphoric acid, N,N'-carbonyl-diimidazole, 2-ethoxy-N-ethoxycarbonyl- 1 ,2-dihydroquino line
(EEDQ), triphenylphosphine/tetrachloromethane, 4-(4,6-dimethoxy[l .3.5]triazin-2- yl)-4-methylmorpholinium chloride hydrate or bromo-tripyrrolidino-phosphonium- hexafluorophosphate.
The compound according to the present invention can be prepared according to the general processes of preparation described above. It will nevertheless be understood that, on the basis of his general knowledge and of available publications, the skilled worker will be able to adapt this method according to the specifics of each of the compounds, which it is desired to synthesise.
On the basis of his general knowledge and of available publications, the skilled worker will also be able to prepare intermediate compound of formula (II) according to the present invention.
The present invention also relates to a fungicidal composition comprising an effective amount of an active material of general formula (I). Thus, according to the present invention, there is provided a fungicidal composition comprising, as an active ingredient, an effective amount of a compound of general formula (I) as defined above and an agriculturally acceptable support, carrier or filler.
In the present specification, the term "support" denotes a natural or synthetic, organic or inorganic material with which the active material is combined to make it easier to apply, notably to the parts of the plant. This support is thus generally inert and should be agriculturally acceptable. The support may be a solid or a liquid. Examples of suitable supports include clays, natural or synthetic silicates, silica, resins, waxes, solid fertilisers, water, alcohols, in particular butanol, organic solvents, mineral and plant oils and derivatives thereof. Mixtures of such supports may also be used.
The composition may also comprise additional components. In particular, the composition may further comprise a surfactant. The surfactant can be an emulsifier, a dispersing agent or a wetting agent of ionic or non-ionic type or a mixture of such surfactants. Mention may be made, for example, of polyacrylic acid salts, lignosulphonic acid salts, phenolsulphonic or naphthalenesulphonic acid salts, polycondensates of ethylene oxide with fatty alcohols or with fatty acids or with fatty amines, substituted phenols (in particular alkylphenols or arylphenols), salts of sulphosuccinic acid esters, taurine derivatives (in particular alkyl taurates), phosphoric esters of polyoxyethylated alcohols or phenols, fatty acid esters of polyols, and derivatives of the above compounds containing sulphate, sulphonate and phosphate functions. The presence of at least one surfactant is generally essential when the active material and/or the inert support are water-insoluble and when the vector agent for the application is water. Preferably, surfactant content may be comprised between 5% and 40% by weight of the composition.
Optionally, additional components may also be included, e.g. protective colloids, adhesives, thickeners, thixotropic agents, penetration agents, stabilisers, sequestering agents. More generally, the active materials can be combined with any solid or liquid additive, which complies with the usual formulation techniques.
In general, the composition according to the invention may contain from 0.05 to 99% (by weight) of active material, preferably 10 to 70% by weight. Compositions according to the present invention can be used in various forms such as aerosol dispenser, capsule suspension, cold fogging concentrate, dustable powder, emulsifϊable concentrate, emulsion oil in water, emulsion water in oil, encapsulated granule, fine granule, flowable concentrate for seed treatment, gas (under pressure),gas generating product, granule, hot fogging concentrate, macrogranule, microgranule, oil dispersible powder, oil miscible flowable concentrate, oil miscible liquid, paste, plant rodlet, powder for dry seed treatment, seed coated with a pesticide, soluble concentrate, soluble powder, solution for seed treatment, suspension concentrate (flowable concentrate), ultra low volume (ulv) liquid, ultra low volume (ulv) suspension, water dispersible granules or tablets, water dispersible powder for slurry treatment, water soluble granules or tablets, water soluble powder for seed treatment and wettable powder.
These compositions include not only compositions which are ready to be applied to the plant or seed to be treated by means of a suitable device, such as a spraying or dusting device, but also concentrated commercial compositions which must be diluted before application to the crop.
The compounds of the invention can also be mixed with one or more insecticides, fungicides, bactericides, attractant acaricides or pheromones or other compounds with biological activity. The mixtures thus obtained have a broadened spectrum of activity. The mixtures with other fungicides are particularly advantageous.
Examples of suitable fungicide mixing partners may be selected in the following lists :
1) a compound capable to inhibit the nucleic acid synthesis like benalaxyl, benalaxyl-M, bupirimate, chiralaxyl, clozylacon, dimethirimol, ethirimol, furalaxyl, hymexazol, mefenoxam, metalaxyl, metalaxyl-M, ofurace, oxadixyl, oxolinic acid ; 2) a compound capable to inhibit the mitosis and cell division like benomyl, carbendazim, diethofencarb, ethaboxam, fuberidazole, pencycuron, thiabendazole thiophanate-methyl, zoxamide;
3) a compound capable to inhibit the respiration for example as Cl-respiration inhibitor like diflumetorim; as Cll-respiration inhibitor like boscalid, carboxin, fenfuram, flutolanil, furametpyr, furmecyclox, mepronil, oxycarboxine, penthiopyrad, thifluzamide; as CHI-respiration inhibitor like amisulbrom, azoxystrobin, cyazofamid, dimoxystrobin, enestrobin, famoxadone, fenamidone, fluoxastrobin, kresoxim- methyl, metominostrobin, orysastrobin, picoxystrobin, pyraclostrobin, trifloxystrobin;
4) a compound capable of to act as an uncoupler like dinocap, fluazinam, meptyldinocap;
5) a compound capable to inhibit ATP production like fentin acetate, fentin chloride, fentin hydroxide, silthiofam;
6) a compound capable to inhibit AA and protein biosynthesis like andoprim, blasticidin-S, cyprodinil, kasugamycin, kasugamycin hydrochloride hydrate, mepanipyrim, pyrimethanil;
7) a compound capable to inhibit the signal transduction like fenpiclonil, fludioxonil, quinoxyfen;
8) a compound capable to inhibit lipid and membrane synthesis like biphenyl, chlozolinate, edifenphos, etridiazole, iodocarb, iprobenfos, iprodione, isoprothiolane, procymidone, propamocarb, propamocarb hydrochloride, pyrazophos, tolclofos- methyl, vinclozolin ; 9) a compound capable to inhibit ergosterol biosynthesis like aldimorph, azaconazole, bitertanol, bromuconazole, cyproconazole, diclobutrazole, difenoconazole, diniconazole, diniconazole-M, dodemorph, dodemorph acetate, epoxiconazole, etaconazole, fenarimol, fenbuconazole, fenhexamid, fenpropidin, fenpropimorph, fluquinconazole, flurprimidol, flusilazole, flutriafol, furconazole, furconazole-cis, hexaconazole, imazalil, imazalil sulfate, imibenconazole, ipconazole, metconazole, myclobutanil, naftifϊne, nuarimol, oxpoconazole, paclobutrazol, pefurazoate, penconazole, prochloraz, propiconazole, prothioconazole, pyributicarb, pyrifenox, simeconazole, spiroxamine, tebuconazole, terbinafme, tetraconazole, triadimefon, triadimenol, tridemorph, triflumizole, triforine, triticonazole, uniconazole, viniconazole, voriconazole; 10) a compound capable to inhibit cell wall synthesis like benthiavalicarb, bialaphos, dimethomorph, flumorph, iprovalicarb, mandipropamid, polyoxins, polyoxorim, validamycin A;
11) a compound capable to inhibit melanine biosynthesis like carpropamid, diclocymet, fenoxanil, phthalide, pyroquilon, tricyclazole;
12) a compound capable to induce a host defence like acibenzolar-S-methyl, probenazole, tiadinil;
13) a compound capable to have a multisite action like Bordeaux mixture, captafol, captan, chlorothalonil, copper naphthenate, copper oxide, copper oxychloride, copper preparations such as copper hydroxide, copper sulphate, dichlofluanid, dithianon, dodine, dodine free base, ferbam, fluorofolpet, folpet, guazatine, guazatine acetate, iminoctadine, iminoctadine albesilate, iminoctadine triacetate, mancopper, mancozeb, maneb, metiram, metiram zinc, oxine-copper, propineb, sulphur and sulphur preparations including calcium polysulphide, thiram, tolylfluanid, zineb, ziram;
14) a compound selected in the following list: (2E)-2-(2-{[6-(3-chloro-2- methylphenoxy)-5-fluoropyrimidin-4-yl]oxy}phenyl)-2-(methoxyimino)-N- methylacetamide, (2E)-2-{2-[({[(lE)-l-(3-{[(E)-l-fluoro-2- phenylvinyl]oxy}phenyl)ethylidene]amino}oxy)methyl]phenyl}-2-(methoxyimino)- N-methylacetamide, l-(4-chlorophenyl)-2-(lH-l,2,4-triazol-l-yl)cycloheptanol, 1- [(4-methoxyphenoxy)methyl]-2,2-dimethylpropyl-lH-imidazole-l-carboxylate, 2,3 ,5 ,6-tetrachloro-4-(methylsulfonyl)pyridine, 2-butoxy-6-iodo-3-propyl-4H- chromen-4-one, 2-chloro-N-(l,l,3-trimethyl-2,3-dihydro-lH-inden-4- yl)nicotinamide, 2-phenylphenol and salts, 3,4,5-trichloropyridine-2,6-dicarbonitrile, 3,4-dichloro-N-(2-cyanophenyl)isothiazole-5-carboxamide, 3-[5-(4-chlorophenyl)- 2,3-dimethylisoxazolidin-3-yl]pyridine, 5-chloro-6-(2,4,6-trifluorophenyl)-N-[(lR)- 1 ,2,2-trimethylpropyl] [ 1 ,2,4]triazolo[ 1 ,5-a]pyrimidin-7-amine, 5-chloro-7-(4- methylpiperidin-l-yl)-6-(2,4,6-trifluorophenyl)[l,2,4]triazolo[l,5-a]pyrimidine, 5- chloro-N-[(lR)-l,2-dimethylpropyl]-6-(2,4,6-trifluorophenyl)[l,2,4]triazolo[l,5- a]pyrimidin-7-amine, 8-hydroxyquinoline sulfate, benthiazole, bethoxazin, capsimycin, carvone, chinomethionat, cufraneb, cyflufenamid, cymoxanil, dazomet, debacarb, dichlorophen, diclomezine, dicloran, difenzoquat, difenzoquat methylsulphate, diphenylamine, ferimzone, flumetover, fluopicolide, fluoroimide, flusulfamide, fosetyl-aluminium, fosetyl-calcium, fosetyl-sodium, hexachlorobenzene, irumamycin, isotianil, methasulfocarb, methyl (2E)-2-{2- [({cyclopropyl[(4-methoxyphenyl)imino]methyl}thio)methyl]phenyl}-3- methoxyacrylate, methyl 1 -(2,2-dimethyl-2,3-dihydro- 1 H-inden- 1 -yl)- 1 H-imidazole- 5-carboxylate, methyl isothiocyanate, metrafenone, mildiomycin, N-[2-(l,3- dimethylbutyl)phenyl]-5-fluoro- 1 ,3-dimethyl- 1 H- pyrazole-4-carboxamide, N-(3',4'-dichloro-5-fluorobiphenyl-2-yl)-3- (difluoromethyl)-l -methyl- lH-pyrazole-4-carboxamide, N-(3-ethyl-3,5,5- trimethylcyclohexyl)-3-(formylamino)-2-hydroxybenzamide, N-(4-chloro-2- nitrophenyl)-N-ethyl-4-methylbenzenesulfonamide, N-(4-chlorobenzyl)-3 - [3 - methoxy-4-(prop-2-yn- 1 -yloxy)phenyl]propanamide, N-[(4- chlorophenyl)(cyano)methyl] -3 - [3 -methoxy-4-(prop-2-yn- 1 - yloxy)phenyl]propanamide, N-[(5-bromo-3-chloropyridin-2-yl)methyl]-2,4- dichloronicotinamide, N-[I -(5-bromo-3-chloropyridin-2-yl)ethyl]-2,4- dichloronicotinamide, N-[I -(5-bromo-3-chloropyridin-2-yl)ethyl]-2-fluoro-4- iodonicotinamide, N-[2-(4-{[3-(4-chlorophenyl)prop-2-yn-l-yl]oxy}-3- methoxyphenyl)ethyl]-N<-(methylsulfonyl)valinamide, N- ((Z)- [(cyclopropylmethoxy)imino] [6-(difluoromethoxy)-2,3-difluorophenyl]methyl} -2- phenylacetamide, N- (2-[ 1 , 1 '-bi(cyclopropyl)-2-yl]phenyl} -3-(difluoromethyl)-, 1 - methyl- 1 H-pyrazole-4-carboxamide, N- {2-[3-chloro-5-(trifluoromethyl)pyridin-2- yl]ethyl} -2-(trifluoromethyl)benzamide, natamycin, N-ethyl-N-methyl-N'- (2-methyl- 5-(trifluoromethyl)-4-[3-(trimethylsilyl)propoxy]phenyl}imidoformamide, N-ethyl- N-methyl-N'- {2-methyl-5-(difluoromethyl)-4-[3-
(trimethylsilyl)propoxy]phenyl} imidoformamide, nickel dimethyldithiocarbamate, nitrothal-isopropyl, O-{l-[(4-methoxyphenoxy)methyl]-2,2-dimethylpropyl} lH- imidazole-1-carbothioate, octhilinone, oxamocarb, oxyfenthiin, pentachlorophenol and salts, phosphorous acid and its salts, piperalin, propamocarb fosetylate, propanosine-sodium, proquinazid, pyribencarb, pyrrolnitrine, quintozene, tecloftalam, tecnazene, triazoxide, trichlamide, valiphenal, zarilamid.
The composition according to the invention comprising a mixture of a compound of formula (I) with a bactericide compound may also be particularly advantageous. Examples of suitable bactericide mixing partners may be selected in the following list : bronopol, dichlorophen, nitrapyrin, nickel dimethyldithiocarbamate, kasugamycin, octhilinone, furancarboxylic acid, oxytetracycline, probenazole, streptomycin, tecloftalam, copper sulphate and other copper preparations.
The fungicidal compositions of the present invention can be used to curatively or preventively control the phytopathogenic fungi of crops. Thus, according to a further aspect of the present invention, there is provided a method for curatively or preventively controlling the phytopathogenic fungi of crops characterised in that a fungicidal composition as hereinbefore defined is applied to the seed, the plant and/or to the fruit of the plant or to the soil in which the plant is growing or in which it is desired to grow.
The composition as used against phytopathogenic fungi of crops comprises an effective and non-phytotoxic amount of an active material of general formula (I).
The expression "effective and non-phytotoxic amount" means an amount of composition according to the invention which is sufficient to control or destroy the fungi present or liable to appear on the crops, and which does not entail any appreciable symptom of phytotoxicity for the said crops. Such an amount can vary within a wide range depending on the fungus to be controlled, the type of crop, the climatic conditions and the compounds included in the fungicidal composition according to the invention.
This amount can be determined by systematic field trials, which are within the capabilities of a person skilled in the art.
The method of treatment according to the present invention is useful to treat propagation material such as tubers or rhizomes, but also seeds, seedlings or seedlings pricking out and plants or plants pricking out. This method of treatment can also be useful to treat roots. The method of treatment according to the present invention can also be useful to treat the overground parts of the plant such as trunks, stems or stalks, leaves, flowers and fruits of the concerned plant.
Among the plants that can be protected by the method according to the present invention, mention may be made of cotton; flax; vine; fruit or vegetable crops such as Rosaceae sp. (for instance pip fruit such as apples and pears, but also stone fruit such as apricots, almonds and peaches), Ribesioidae sp., Juglandaceae sp., Betulaceae sp., Anacardiaceae sp., Fagaceae sp., Moraceae sp., Oleaceae sp., Actinidaceae sp., Lauraceae sp., Musaceae sp. (for instance banana trees and plantins), Rubiaceae sp., Theaceae sp., Sterculiceae sp., Rutaceae sp. (for instance lemons, oranges and grapefruit); Solanaceae sp. (for instance tomatoes), Liliaceae sp., Asteraceae sp. (for instance lettuces), Umbelliferae sp., Cruciferae sp., Chenopodiaceae sp., Cucurbitaceae sp., Papilionaceae sp. (for instance peas), Rosaceae sp. (for instance strawberries); major crops such as Graminae sp. (for instance maize, lawn or cereals such as wheat, rice, barley and triticale), Asteraceae sp. (for instance sunflower), Cruciferae sp. (for instance colza), Fabacae sp. (for instance peanuts), Papilionaceae sp. (for instance soybean), Solanaceae sp. (for instance potatoes), Chenopodiaceae sp. (for instance beetroots); horticultural and forest crops; as well as genetically modified homologues of these crops.
Among the diseases of plants or crops that can be controlled by the method according to the present invention, mention may be made of : Powdery mildew diseases such as :
Blumeria diseases, caused for example by Blumeria graminis; Podosphaera diseases, caused for example by Podosphaera leucotricha; Sphaerotheca diseases, caused for example by Sphaerotheca fuliginea; Uncinula diseases, caused for example by Uncinula necator; Rust diseases such as :
Gymnosporangium diseases, caused for example by Gymnosporangium sabinae;
Hemileia diseases, caused for example by Hemileia vastatrix; Phakopsora diseases, caused for example by Phakopsora pachyrhizi or Phakopsora meibomiae;
Puccinia diseases, caused for example by Puccinia recondita; Uromyces diseases, caused for example by Uromyces appendiculatus; Oomycete diseases such as :
Bremia diseases, caused for example by Bremia lactucae; Peronospora diseases, caused for example by Peronospora pisi or P. brassicae;
Phytophthora diseases, caused for example by Phytophthora infestans; Plasmopara diseases, caused for example by Plasmopara viticola; Pseudoperonospora diseases, caused for example by Pseudoperonospora humuli or Pseudoperonospora cubensis;
Pythium diseases, caused for example by Pythium ultimum; Leafspot, leaf blotch and leaf blight diseases such as :
Alternaria diseases, caused for example by Alternaria solani; Cercospora diseases, caused for example by Cercospora beticola; Cladiosporum diseases, caused for example by Cladiosporium cucumerinum;
Cochlio bolus diseases, caused for example by Cochliobolus sativus; Colletotrichum diseases, caused for example by Colletotrichum lindemuthanium;
Cycloconium diseases, caused for example by Cycloconium oleaginum; Diaporthe diseases, caused for example by Diaporthe citri;
Elsinoe diseases, caused for example by Elsinoe fawcettii; Gloeosporium diseases, caused for example by Gloeosporium laeticolor;
Glomerella diseases, caused for example by Glomerella cingulata;
Guignardia diseases, caused for example by Guignardia bidwelli;
Leptosphaeria diseases, caused for example by Leptosphaeria maculans; Leptosphaeria nodorum;
Magnaporthe diseases, caused for example by Magnaporthe grisea;
Mycosphaerella diseases, caused for example by Mycosphaerella graminicola; Mycosphaerella arachidicola; Mycosphaerella fijiensis;
Phaeosphaeria diseases, caused for example by Phaeosphaeria nodorum; Pyrenophora diseases, caused for example by Pyrenophora teres;
Ramularia diseases, caused for example by Ramularia collo-cygni;
Rhynchosporium diseases, caused for example by Rhynchosporium secalis;
Septoria diseases, caused for example by Septoria apii or Septoria lycopercisi;
Typhula diseases, caused for example by Typhula incarnata; Venturia diseases, caused for example by Venturia inaequalis;
Root and stem diseases such as :
Corticium diseases, caused for example by Corticium graminearum;
Fusarium diseases, caused for example by Fusarium oxysporum;
Gaeumannomyces diseases, caused for example by Gaeumannomyces graminis;
Rhizoctonia diseases, caused for example by Rhizoctonia solani;
Tapesia diseases, caused for example by Tapesia acuformis;
Thielaviopsis diseases, caused for example by Thielaviopsis basicola; Ear and panicle diseases such as : Alternaria diseases, caused for example by Alternaria spp.;
Aspergillus diseases, caused for example by Aspergillus flavus;
Cladosporium diseases, caused for example by Cladosporium spp.;
Claviceps diseases, caused for example by Claviceps purpurea;
Fusarium diseases, caused for example by Fusarium culmorum; Gibberella diseases, caused for example by Gibber ella zeae;
Monographella diseases, caused for example by Monographella nivalis; Smut and bunt diseases such as :
Sphacelotheca diseases, caused for example by Sphacelotheca reiliana;
Tilletia diseases, caused for example by Tilletia caries; Urocystis diseases, caused for example by Urocystis occulta;
Ustilago diseases, caused for example by Ustilago nuda; Fruit rot and mould diseases such as :
Aspergillus diseases, caused for example by Aspergillus flavus;
Botrytis diseases, caused for example by Botrytis cinerea;
Penicillium diseases, caused for example by Penicillium expansum; Sclerotinia diseases, caused for example by Sclerotinia sclerotiorum;
Verticilium diseases, caused for example by Verticilium alboatrum; Seed and soilborne decay, mould, wilt, rot and damping-off diseases :
Fusarium diseases, caused for example by Fusarium culmorum;
Phytophthora diseases, caused for example by Phytophthora cactorum; Pythium diseases, caused for example by Pythium ultimum;
Rhizoctonia diseases, caused for example by Rhizoctonia solani;
Sclerotium diseases, caused for example by Sclerotium rolfsii;
Microdochium diseases, caused for example by Microdochium nivale; Canker, broom and dieback diseases such as : Nectria diseases, caused for example by Nectria galligena;
Blight diseases such as :
Monilinia diseases, caused for example by Monilinia laxa; Leaf blister or leaf curl diseases such as :
Taphrina diseases, caused for example by Taphrina deformans; Decline diseases of wooden plants such as :
Esca diseases, caused for example by Phaemoniella clamydospora; Diseases of flowers and Seeds such as :
Botrytis diseases, caused for example by Botrytis cinerea; Diseases of tubers such as : Rhizoctonia diseases, caused for example by Rhizoctonia solani;
Helminthosporium diseases, caused for example by Helminthosporium solani.
The fungicide composition according to the present invention may also be used against fungal diseases liable to grow on or inside timber. The term "timber" means all types of species of wood, and all types of working of this wood intended for construction, for example solid wood, high-density wood, laminated wood, and plywood. The method for treating timber according to the invention mainly consists in contacting one or more compounds of the present invention, or a composition according to the invention; this includes for example direct application, spraying, dipping, injection or any other suitable means. The dose of active material usually applied in the treatment according to the present invention is generally and advantageously between 10 and 800 g/ha, preferably between 50 and 300 g/ha for applications in foliar treatment. The dose of active substance applied is generally and advantageously between 2 and 200 g per 100 kg of seed, preferably between 3 and 15O g per 100 kg of seed in the case of seed treatment. It is clearly understood that the doses indicated above are given as illustrative examples of the invention. A person skilled in the art will know how to adapt the application doses according to the nature of the crop to be treated.
The fungicidal composition according to the present invention may also be used in the treatment of genetically modified organisms with the compounds according to the invention or the agrochemical compositions according to the invention. Genetically modified plants are plants into whose genome a heterologous gene encoding a protein of interest has been stably integrated. The expression "heterologous gene encoding a protein of interest" essentially means genes which give the transformed plant new agronomic properties, or genes for improving the agronomic quality of the transformed plant.
The compositions according to the present invention may also be used for the preparation of composition useful to curatively or preventively treat human and animal fungal diseases such as, for example, mycoses, dermatoses, trichophyton diseases and candidiases or diseases caused by Aspergillus spp., for example Aspergillus fumigatus.
The aspects of the present invention will now be illustrated with reference to the following tables of compounds and examples. The following Table illustrates in a non-limiting manner examples of fungicidal compounds according to the present invention. In the following Examples, M+l (or M-I) means the molecular ion peak, plus or minus 1 a.m.u. (atomic mass units) respectively, as observed in mass spectroscopy and M (Apcl+) means the molecular ion peak as it was found via positive atmospheric pressure chemical ionisation in mass spectroscopy. Table A
Figure imgf000028_0001
Figure imgf000028_0002
Table B
Figure imgf000029_0001
Figure imgf000029_0002
Table C
Figure imgf000030_0001
Figure imgf000030_0002
Table D
Figure imgf000031_0001
Figure imgf000031_0002
Table E
Figure imgf000032_0001
Figure imgf000032_0002
Table F
Figure imgf000033_0001
Figure imgf000033_0002
Examples of process for the preparation of the compound of general formula (I)
Example 1 : Preparation of 2-chloro-N-(2-ethvnylcvclohexyl)nicotinamide (Compound E-I)
185 mg of 2-ethynylcyclohexanamine (0.0015 mol) and 0.272 ml of triethylamine (0.00195 mol) are diluted in 15 ml of tetrahydrofuran. 290 mg
(0.00165 mol) of 2-chloronicotinoyl chloride in solution in 2 ml of tetrahydrofuran are added to the reaction mixture after five minutes of stirring. The reaction mixture is stirred at 600C for four hours.
After concentration of the solvent, ethyl acetate is added (25 ml) to the reaction mixture, which is washed twice with water (25ml).
After separation, the organic phase is dried over magnesium sulfate, filtered, concentrated to dryness and purified on silica (ethyl acetate/heptane = 60/40) to yield to 300 mg of 2-chloro-N-(2-ethynylcyclohexyl)nicotinamide (76%). Mass spectrum : [M+ 1] = 263.
Examples of biological activity of the compound of general formula (I)
Example A : in vivo test on Mycosphaerella graminicola (Wheat Leaf Spot)
The active ingredients tested are prepared by homogenization in a mixture of DMSO/acetone/tween, then diluted with water to obtain the desired active material concentration.
Wheat plants (Scipion variety), sown on a 50/50 peat soil-pozzolana substrate in starter cups and grown at 12°C, are treated at the 1-leaf stage (10 cm tall) by spraying with the aqueous suspension described above. Plants, used as controls, are treated with an aqueous solution not containing the active material.
After 24 hours, the plants are contaminated by spraying them with an aqueous suspension of Mycosphaerella graminicola spores (500 000 spores per ml). The spores are collected from a 7-day-old culture .The contaminated wheat plants are incubated for 72 hours at 18°C and at 100% relative humidity, and then for 21 to 28 days at 90% relative humidity.
Grading (% of efficacy) is carried out 21 to 28 days after the contamination, in comparison with the control plants.
Under these conditions, good (at least 70%) protection is observed at a dose of 500 ppm with the following compounds : Al, A2, Cl, .Dl, Fl, F2 and F3.

Claims

A compound of general formula (I)
Figure imgf000036_0001
in which :
- R1 is a hydrogen atom, a halogen atom, a Ci-Cβ-alkyl, a C2-C6-alkenyl, a C2-C6-alkynyl, a tri(Ci-C8-alkyl)silyl, a C3-C6-cycloalkyl or a C3-C6- halogenocycloalkyl having 1 to 5 halogen atoms; - R2 and R3 are chosen independently of each other as being a hydrogen atom, a halogen atom, a Ci-Cβ-alkyl, a C2-C6-alkenyl, a C2-C6-alkynyl, a Id(Ci-Cs- alkyl)silyl, a C3-C6-cycloalkyl or a C3-C6-halogenocycloalkyl having 1 to 5 halogen atoms;
- R4 and R5 are chosen independently of each other as being a hydrogen atom, a halogen atom, a Ci-Cβ-alkyl, a C2-C6-alkenyl, a C2-C6-alkynyl, a Id(Ci-Cs- alkyl)silyl, a C3-C6-cycloalkyl or a C3-C6-halogenocycloalkyl having 1 to 5 halogen atoms; or R2 or R3 may form together with R4 or R5 a C3-C7-cycloalkyl;
- R6 is a hydrogen atom, a Ci-Cβ-alkyl, or a C3-C7-CyC loalkyl; and - Het represents a 5-, 6- or 7-membered non-fused heterocycle with one, two or three heteroatoms which may be the same or different, Het being linked by a carbon atom; Het being substituted in ortho position by a substituent chosen as being a halogen atom, a nitro group, a cyano group, a sulfanyl group, a pentafluoro-λ6- sulfanyl group, a Ci-Cs-alkyl, a Ci-Cs-halogenoalkyl having 1 to 5 halogen atoms, a C2-C8-alkenyl, a C2-Cs-alkynyl, a Ci-Cs-alkoxy, a Ci-Cs-halogenoalkoxy having 1 to 5 halogen atoms, a
Figure imgf000036_0002
a Ci-Cs-alkylsulfanyl or a Ci-Cs- halogenoalkylsulfanyl having 1 to 5 halogen atoms; and optionally substituted in any other position by one or further substituents chosen independently of each other from a halogen atom, a nitro group, a cyano group, a sulfanyl group, a pentafluoro-λ6- sulfanyl group, a formyl group, a formyloxy group, a formylamino group, a carboxy group, a Ci-Cs-alkyl, a Ci-Cs-halogenoalkyl having 1 to 5 halogen atoms, a C2-C8- alkenyl, a C2-Cs-alkynyl, a Ci-Cs-alkoxy, a Ci-Cs-halogenoalkoxy having 1 to 5 halogen atoms, a
Figure imgf000037_0001
a Ci-Cs-alkylsulfanyl or a Ci-Cs- halogenoalkylsulfanyl having 1 to 5 halogen atoms; as well as its salts, N-oxydes, metallic complexes, metalloidic complexes and optically active isomers.
2. A compound according to claim 1 , characterised in that R1 is chosen as being a hydrogen atom, a Ci-Cβ-alkyl or a C3-C7-cycloalkyl.
3. A compound according to claim 1 or 2, characterised in that R2 and R3 are chosen independently of each other as being a hydrogen atom, a Ci-Cβ-alkyl or a C3-
C7-cycloalkyl.
4. A compound to nay of the claims 1 to 3, characterised in that R4 and R5 are chosen independently of each other as being a hydrogen atom, a Ci-Cβ-alkyl or a C3- Cy-cycloalkyl.
5. compound according to claim 1 or 2, characterised in that R2 or R3 form together with R4 or R5 a C3-C7-cycloalkyl.
6. A compound according to any of the claims 1 to 5, characterised in that a five membered ring heterocycle.
7. A compound according to any of the claims 1 to 5, characterised in that a six membered ring heterocycle.
8. A compound according to any of the claims 1 to 7, characterised in that Het is substituted in ortho position by a halogen atom, a Ci-Cs-alkyl, a Ci-Cs-halogenoalkyl having 1 to 5 halogen atoms, a Ci-Cs-alkoxy or a Ci-Cs-halogenoalkoxy having 1 to 5 halogen atoms.
9. A compound according to any of the claims 1 to 8, characterised in that Het is substituted in any other position than ortho position by a halogen atom or a C1-C8- alkyl,.
10. A process for the preparation of a compound of general formula (I) as defined in claim 1, which comprises reacting which comprises reacting a N- alkynylcarboxamide derivative of general formula (II) or one of its salt :
Figure imgf000038_0001
(H) in which R1, R2, R3, R4, R5, and R6 are as defined in claim 1; with a carboxylic acid derivative of the general formula (III)
Figure imgf000038_0002
in which : - Het is as defined in claim 1; and
- L1 is a leaving group chosen as being a halogen atom, a hydroxyl group, -ORa, - OCORa, Ra being a Ci-C6 alkyl, a Ci-C6 haloalkyl, a benzyl, 4-methoxybenzyl, pentafluorophenyl or a group of formula ^O^-Het ;
O in the presence of a catalyst and, if L1 is a hydroxyl group, in the presence of a condensing agent.
11. A fungicide composition comprising an effective amount of a compound according to any of the claims 1 to 9 and an agriculturally acceptable support.
12. A method for preventively or curatively combating the phytopathogenic fungi of crops, characterised in that an effective and non-phytotoxic amount of a composition according to claim 11 is applied to the plant seeds or to the plant leaves and/or to the fruits of the plants or to the soil in which the plants are growing or in which it is desired to grow them.
PCT/EP2008/050014 2007-01-03 2008-01-02 New n-alkynylcarboxamide derivatives WO2008081017A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07100063.2 2007-01-03
EP07100063 2007-01-03

Publications (1)

Publication Number Publication Date
WO2008081017A1 true WO2008081017A1 (en) 2008-07-10

Family

ID=37969863

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2008/050014 WO2008081017A1 (en) 2007-01-03 2008-01-02 New n-alkynylcarboxamide derivatives

Country Status (3)

Country Link
AR (1) AR064564A1 (en)
CL (1) CL2008000005A1 (en)
WO (1) WO2008081017A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011151370A1 (en) 2010-06-03 2011-12-08 Bayer Cropscience Ag N-[(het)arylalkyl)] pyrazole (thio)carboxamides and their heterosubstituted analogues
WO2012093100A1 (en) * 2011-01-05 2012-07-12 Syngenta Participations Ag Pyrazol-4-yl carboxamide derivatives as microbiocides
WO2020244970A1 (en) * 2019-06-06 2020-12-10 Basf Se New carbocyclic pyridine carboxamides

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4064135A (en) * 1976-07-19 1977-12-20 Syntex (U.S.A.) Inc. Certain thiazole-5-carboxamide compounds
WO1992005159A1 (en) * 1990-09-19 1992-04-02 Hoechst Aktiengesellschaft 2-phenyl-pyrimidines, process for producing the same, agents containing the same and their use as fungicides
WO2003010149A1 (en) * 2001-07-25 2003-02-06 Bayer Cropscience Ag Pyrazolylcarboxanilides as fungicides
US20060019831A1 (en) * 2002-10-18 2006-01-26 Basf Aktiengesellschaft 1-phenylpyrrolidine-2-one-3-carboxamides
WO2006061215A2 (en) * 2004-12-11 2006-06-15 Bayer Cropscience Ag 2-alkyl-cycloalk(en)yl-carboxamides
WO2006122955A1 (en) * 2005-05-18 2006-11-23 Bayer Cropscience Sa New 2-pyridinylcycloalkylcarboxamide derivatives as fungicides.

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4064135A (en) * 1976-07-19 1977-12-20 Syntex (U.S.A.) Inc. Certain thiazole-5-carboxamide compounds
WO1992005159A1 (en) * 1990-09-19 1992-04-02 Hoechst Aktiengesellschaft 2-phenyl-pyrimidines, process for producing the same, agents containing the same and their use as fungicides
WO2003010149A1 (en) * 2001-07-25 2003-02-06 Bayer Cropscience Ag Pyrazolylcarboxanilides as fungicides
US20060019831A1 (en) * 2002-10-18 2006-01-26 Basf Aktiengesellschaft 1-phenylpyrrolidine-2-one-3-carboxamides
WO2006061215A2 (en) * 2004-12-11 2006-06-15 Bayer Cropscience Ag 2-alkyl-cycloalk(en)yl-carboxamides
WO2006122955A1 (en) * 2005-05-18 2006-11-23 Bayer Cropscience Sa New 2-pyridinylcycloalkylcarboxamide derivatives as fungicides.

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
CHEMIKER-ZEITUNG , 114(12), 381-2 CODEN: CMKZAT; ISSN: 0009-2894, 1990 *
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; ENGELBACH, MARTIN ET AL: "Synthesis of annulated 7-azaindolizines by intramolecular [3+2] cycloaddition with pyrazinium dicyanomethylides", XP002432842, retrieved from STN Database accession no. 1995:332238 *
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; SEITZ, GUNTHER ET AL: "Inverse, intramolecular [4 + 2]-cycloadditions with activated 1,2,4-triazine-6-carboxylic acid alkynyl amides", XP002432841, retrieved from STN Database accession no. 1991:207082 *
HETEROCYCLES , 40(1), 69-72 CODEN: HTCYAM; ISSN: 0385-5414, 1995 *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011151370A1 (en) 2010-06-03 2011-12-08 Bayer Cropscience Ag N-[(het)arylalkyl)] pyrazole (thio)carboxamides and their heterosubstituted analogues
JP2013532138A (en) * 2010-06-03 2013-08-15 バイエル・クロップサイエンス・アーゲー N-[(Heta) arylalkyl)] pyrazole (thio) carboxamides and their hetero-substituted analogues
WO2012093100A1 (en) * 2011-01-05 2012-07-12 Syngenta Participations Ag Pyrazol-4-yl carboxamide derivatives as microbiocides
CN103313972A (en) * 2011-01-05 2013-09-18 先正达参股股份有限公司 Pyrazol-4-yl carboxamide derivatives as microbiocides
US8653003B2 (en) 2011-01-05 2014-02-18 Syngenta Participations Ag Pyrazol-4-yl carboxamide derivatives as microbiocides
CN103313972B (en) * 2011-01-05 2015-04-08 先正达参股股份有限公司 Pyrazol-4-yl carboxamide derivatives as microbiocides
WO2020244970A1 (en) * 2019-06-06 2020-12-10 Basf Se New carbocyclic pyridine carboxamides

Also Published As

Publication number Publication date
CL2008000005A1 (en) 2008-07-11
AR064564A1 (en) 2009-04-08

Similar Documents

Publication Publication Date Title
EP1954674B1 (en) New n-phenethylcarboxamide derivatives
EP1960379B1 (en) N-(1-alkyl-2-phenylethyl)-carboxamide derivatives and use thereof as fungicides
US8283349B2 (en) Fungicide N-(3-phenylpropyl) carboxamide derivatives
US20080096932A1 (en) 3-Pyridinylethylcarboxamide Derivatives as Fungicides
EP1879878B1 (en) Heterocyclylethylheterocyclylcarboxamide derivatives as fungicides
US20080096933A1 (en) 4-Pyridinylethylcarboxamide Derivatives Useful as Fungicides
EP1885712A1 (en) New 2-pyridinylcycloalkylcarboxamide derivatives as fungicides.
EP1960350B1 (en) New n-(1-methyl-2phenylethyl)benzamide derivatives
WO2006108792A1 (en) New heterocyclylethylbenzamide derivatives
EP1937637B1 (en) New n-alkyl-heterocyclyl carboxamide derivatives
WO2008081011A1 (en) N-methyl carboxamide derivatives useful as fungicides
US20100063155A1 (en) N-(3-phenylpropyl)benzamide derivatives
WO2008081017A1 (en) New n-alkynylcarboxamide derivatives
US20090209589A1 (en) N-[(pyridin-2-yl) methoxy] hetrocyclyl carboxamide derivatives and related compounds as fungicides
WO2008061866A1 (en) New benzamide derivatives
WO2008046838A2 (en) N- (3-pyridin-2-ylpropyl) benzamide derivatives as fungicides
WO2008081016A1 (en) New n-alkynylbenzamide derivatives

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08701201

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08701201

Country of ref document: EP

Kind code of ref document: A1